NBER WORKING PAPER SERIES

ESTIMATING AND FORECASTING DISEASE SCENARIOS FOR COVID-19 WITH
AN SIR MODEL
Andrew Atkeson
Karen Kopecky
Tao Zha
Working Paper 27335
http://www.nber.org/papers/w27335

NATIONAL BUREAU OF ECONOMIC RESEARCH
1050 Massachusetts Avenue
Cambridge, MA 02138
June 2020

Andrew Atkeson has benefited from conversations with James Stock on this topic. We are
grateful to Hongyi Fu for superlative research assistance. The views expressed herein are those of
the authors and do not necessarily reflect the views of the Federal Reserve Banks of Atlanta and
Minneapolis, the Federal Reserve System, or the National Bureau of Economic Research.
NBER working papers are circulated for discussion and comment purposes. They have not been
peer-reviewed or been subject to the review by the NBER Board of Directors that accompanies
official NBER publications.
Â© 2020 by Andrew Atkeson, Karen Kopecky, and Tao Zha. All rights reserved. Short sections of
text, not to exceed two paragraphs, may be quoted without explicit permission provided that full
credit, including Â© notice, is given to the source.

Estimating and Forecasting Disease Scenarios for COVID-19 with an SIR Model
Andrew Atkeson, Karen Kopecky, and Tao Zha
NBER Working Paper No. 27335
June 2020
JEL No. C01,C02,C11
ABSTRACT
This paper presents a procedure for estimating and forecasting disease scenarios for COVID-19
using a structural SIR model of the pandemic. Our procedure combines the flexibility of
noteworthy reduced-form approaches for estimating the progression of the COVID-19 pandemic
to date with the benefits of a simple SIR structural model for interpreting these estimates and
constructing forecast and counterfactual scenarios. We present forecast scenarios for a
devastating second wave of the pandemic as well as for a long and slow continuation of current
levels of infections and daily deaths. In our counterfactual scenarios, we find that there is no clear
answer to the question of whether earlier mitigation measures would have reduced the long run
cumulative death toll from this disease. In some cases, we find that it would have, but in other
cases, we find the opposite â€” earlier mitigation would have led to a higher long-run death toll.

Andrew Atkeson
Bunche Hall 9381
Department of Economics
UCLA
Box 951477
Los Angeles, CA 90095-1477
and NBER
andy@atkeson.net
Karen Kopecky
Research Department
Federal Reserve Bank of Atlanta
1000 Peachtree ST NE
Atlanta, GA 30309
karen.kopecky@atl.frb.org

Tao Zha
Department of Economics
Emory University
Rich Memorial Building
1602 Fishburne Drive
Atlanta, GA 30322-2240
and Federal Reserve Bank of Atlanta
and also NBER
tzha@emory.edu

1

Introduction

This paper presents a procedure for estimating and forecasting disease scenarios for
COVID-19 using a simple structural SIR model of the pandemic. An SIR model
is a Markov model of the spread of a pandemic in a population in which the total
population is divided into categories of being susceptible to the disease (S), actively
infected with the disease (I), recovered and no longer contagious (R), or dead (D).
How a pandemic plays out over time is determined by the transition rates at which
people move between these states.
Our procedure for estimating this SIR model and constructing forecasts combines
the flexibility of noteworthy reduced-form approaches for estimating the progression of the COVID-19 pandemic with the benefits of a simple structural model for
interpreting these estimates and constructing scenarios for the development of the
pandemic going forward. We implement our method to estimate the model using data
on deaths for large states and Census regions of the United States and for a number
of additional countries. We then use the estimated model to conduct counterfactuals
studying how the pandemic would have progressed under alternative scenarios for
mitigating the transmission of the disease and to construct forecasts under various
scenarios for the transmission of the disease going forward.
Our procedure for estimating the SIR model and using it for counterfactuals and
forecasting has three steps.
In step 1, for each geographic region that we consider, we estimate an empirical
specification for cumulative deaths due to COVID-19 observed between an initial
date t0 at which cumulative deaths reaches a threshold of 50 and the present. The
specific empirical specification we consider models the data on daily deaths in the
region as derived from a mixture of Weibull functions. This specification allows for a
very flexible model of the observed data on cumulative deaths, daily deaths, and the
change in daily deaths over time (corresponding to the first and second derivatives
of cumulative deaths with respect to time).

1

Conceptually, the estimation conducted in this first step is similar to the widely
cited empirical model for cumulative deaths developed by researchers at the Institute
for Health Metrics and Evaluation (IHME) at the University of Washington.1 See
also Linton (2020)2 for a similar reduced-form approach to modeling the evolution of
cases and deaths over time. Where we differ from these reduced-form approaches to
estimation and forecasting is in how we then use a structural SIR model to interpret
this empirical model of observed deaths due to COVID and to develop counterfactual
scenarios and scenarios for forecasting the progression of the disease in the next two
steps.
In step 2, we use the best available information to choose parameters for the fatality
rate (the fraction of active infections that end in death) and the recovery rate (the
rate per unit time at which people who are actively infected stop being infectious)
of COVID-19, or a range for these parameters to be considered. Given these fatality
and recovery rates, we then use the equations of the SIR model to recover the time
paths of the distribution of the population across states S(t), I(t), R(t), D(t) and the
time path of the effective reproduction number of the disease (the ratio of the rate
at which actively infected people spread the infection to the recovery rate) between
the initial date t0 and the present for which the model fits exactly the empirical
specification for deaths from the initial date t0 to the present estimated in step 1.
Note that our estimates in this step of the evolution of the transmission rate of the
disease over time in different geographies do not use any additional ex-ante structural
assumptions beyond those imposed in our empirical estimates in step 1 and by the
basic assumptions of the SIR model.
In this way, in step 2, we use the SIR model to give a structural interpretation of
the empirical specification for the data on deaths estimated in step 1 in terms of a
full model of the progression of the pandemic. Not only do we uncover an estimate
of the current distribution of the population across states S, I, R and D, but also we
1

See the working paper discussion of the IMHE forecasting model here https://www.medrxiv.
org/content/10.1101/2020.04.21.20074732v1
2
See updated forecasts at http://covid.econ.cam.ac.uk/linton-uk-covid-cases-predicted-peak

2

can use the model to decompose the evolution over time of the effective reproduction
number of the disease in each geographic region into a component due to changes
in the transmission rate of the disease (due to changes in behavior or mitigation
efforts) and a component due to changes in the population of agents that continue
to be susceptible to the disease.
In step 3, we use our structural model to address questions about future scenarios
for the evolution of the pandemic and to conduct counterfactual exercises regarding
how the pandemic would have progressed in a region if the transmission rate of
the disease in that region had followed a different path due to different timing and
severity of disease mitigation efforts. We construct forecast scenarios for the evolution
of the pandemic going forward from the present date by positing alternative paths
for the evolution of the transmission rate of the disease going forward from the
present date and solving the SIR model starting from the current distribution of
the population across states S, I, R and D estimated in step 2. We construct
counterfactual scenarios for the evolution of the pandemic by considering alternative
paths for the transmission rate of the disease both historically (corresponding to
alternative initial timing of mitigation efforts) and going forward and solving the
SIR model starting from the initial distribution of the population across states at
date t0 . In this regard, our forecast and counterfactual scenarios are based on a
structural disease model as is done by some leading epidemiological models.3 We see
the transparency of our model estimation approach as one of its key advantages in
helping the reader interpret our forecast and counterfactual results.
We apply this procedure to estimate our SIR model and to construct forecast and
counterfactual scenarios for ten large U.S. states and nine U.S. Census Regions as
well as a number of other countries.
We model the patterns of daily deaths with a mixture of Weibull functions. We
3

See, for example https://www.medrxiv.org/content/10.1101/2020.03.21.20040303v2.full.pdf
for a description of the forecasting project at Columbiaâ€™s Mailman School of Public Health using a structural SEIR model that estimates the impact of mitigation measures on the normalized
transmission rate.

3

use the Bayesian procedure to fit these functions to daily deaths for each state or
Census region or country. The residual term in this nonlinear regression follows a
Markov-switching process with multiple regimes to capture large spikes of deaths as
random events in one regime and small death fluctuations in another regime. The
number of Weibull functions needed to fit death data is determined by the marginal
data density (the marginal likelihood).
The Bayesian procedure allows us to characterize the uncertainty about the parameters of Weibull functions by simulating random draws of all the parameters in an
estimated mixture of Weibull functions from the posterior distribution. We feed each
posterior draw of these parameters into our SIR model and solve for paths of all the
SIR model variables such as the transmission rate and the fraction still susceptible
within the sample as well as out of the sample. We then generate the posterior distributions of these model variables, which are used to produce probability (uncertainty)
bands of various variables both in and out of sample.
As of the end of May, 2020, our key findings can be summarized as follows.
First, across almost all regions and countries that we consider, the growth of the
pandemic as measured by its effective reproduction number has fallen dramatically
from the initial date at which cumulative deaths reached 50 and the present. In many
cases, we see declines of the effective reproduction number from levels well above 3
to levels well below 1. This rapid decline in the effective reproduction number of
the disease seen in the regions that we consider accounts for the observation that
infections and deaths have not reached the levels that were forecast by some in mid
March. At the same time, we find that the estimated fraction of the population
that remains susceptible to the disease is very high in almost all regions and the
fraction of the population that is actively infected, while not extraordinarily high, is
substantially larger than it was in early March.
Second, we find that in most regions and countries that we consider, the current
levels of susceptible and infected agents are both sufficiently large to trigger the
rapid emergence of a very large second wave of the pandemic if the relaxation of
4

mitigation measures leads to transmission rate of the disease to return to levels seen
in early April (consistent with an effective reproduction number close to 2). Under
this scenario, the pandemic would progress very quickly through the population and
would extinguish itself in 90-100 days. Under this scenario, daily deaths would rise
to very high levels over the next few months â€” much higher levels than have been
seen in the United States to date, even in New York City. This scenario corresponds
to a devastating but short pandemic.
In contrast, if disease mitigation efforts going forward are successful in constraining
the transmission of the disease to levels similar to those seen in late April (consistent
with an effective reproduction number close to 1.3), then the number of infections
and daily deaths would remain roughly constant or grow only slowly across most
regions for many months going forward. In many regions, under this second scenario,
the cumulative burden of the disease in terms of infections and deaths would be
substantially reduced, but the pandemic would drag on for a long time.
Third, in our counterfactual exercises, we find no consistent pattern across regions
regarding the answer to the question of whether earlier or later mitigation efforts
would have reduced the cumulative death toll from the disease. The answer to this
question regarding the impact of changes in the timing of mitigation on cumulative
deaths depends on the data for each region and on the assumed scenario for the
transmission of the disease going forward from the present date. We illustrate this
finding with a focus on our estimates for Pennsylvania. We consider counterfactual
scenarios under which the decline in the transmission rate of the disease estimated in
these locations started seven days later than is estimated. We show that under one
scenario, this counterfactual timing of the mitigation of the disease leads to a large
increase in long-run cumulative deaths and in another scenario to a large decrease in
long-run cumulative deaths. We give an intuitive explanation for this finding in terms
of the key role played by the fraction of the infected population at the moment when
the population reaches herd immunity in shaping the long-run cumulative deaths
from the disease in an SIR model as noted in Toda (2020) and Rachel (2020).

5

To implement our estimation procedure, we have to obtain estimates of the fatality
and recovery rates for COVID-19 from outside sources. In particular, the first two
steps of our estimation procedure highlight the problem of identifying the fatality and
recovery rates of the disease from time series data on deaths alone discussed in Atkeson (2020), Stock (2020), Korolev (2020), and Lourenco et al. (2020). Specifically,
we obtain the following lack-of-identification result: given any empirical specification for data on cumulative deaths that is strictly increasing and twice differentiable,
then, for a large set of parameters for the fatality and recovery rates of the disease,
there exists a path for the transmission rate of the disease over time and an initial
distribution of the population across states (at the initial date t0 ) for which the SIR
model with these parameters reproduces this specification for the data on deaths
exactly. The only restrictions on the set of fatality and recovery rates implied by the
death data are that the fractions of recovered and infected agents cannot exceed one
and that the effective reproduction number can never be negative.4
Our procedure in step 2 for recovering an estimate of the evolution of the effective
reproduction number over time from the empirical specification for deaths estimated
in step 1 is related to widely cited methods for using data on the evolution of the
number of active infections or deaths over time to estimate the effective reproduction
number of a disease developed in Wallinga and Teunis (2004), Wallinga and Lipsitch
(2006), Cori et al. (2013), and Chowell et al. (2007). Under these methodologies,
the effective reproduction number of a disease at a point in time is obtained from
an estimate of the growth rate of active infections at that point in time and of the
recovery rate of the disease.5 Under the assumption of a constant fatality rate, our
SIR model implies that one can infer the growth rate of active infections from the
growth rate of new deaths. Our empirical specification of daily deaths as following
a mixture of Weibull functions with regime-switching errors allows us a very flexible
4

These restrictions put lower bounds on the fatality rate and on the recovery rate.
Our simple SIR model imposes an exponential distribution of recovery times. More generally,
the length of time over which an infected person is contagious may follow some other distribution
and then one must also estimate the distribution of serial intervals of the disease. See https:
//staff.math.su.se/hoehle/blog/2020/04/15/effectiveR0.html for a discussion.
5

6

model for modeling both the first and second derivatives of cumulative deaths while
also allowing us to deal econometrically with the fact that the observed data on
daily deaths is subject to a great deal of noise. We see the fact that we can construct
Bayesian uncertainty bands for our estimates as one of the primary advantages of
our specific empirical specification.
Our work is related to Fernandez-Villaverde and Jones (2020), who also use the
death data to estimate a similar structural model. Both papers address some common
identification issues related to the fatality and recovery rates. Our paper, however,
differs from their work in several important respects. First, we use the full Bayesian
procedure to characterize the uncertainty of death patterns. This approach enables
us to provide probability bands of all the SIR model variables in and out of the
sample. Second, we focus on the issue of how earlier or later mitigation measures
would have impacted the total death toll from the disease.6 Our estimation shows
a considerable degree of heterogeneity in death impacts across geographic regions.
Third, we provide a critical analysis of how such heterogeneous results are related
to what we call â€œthe IS curve,â€ which is the phase diagram showing the relationship
between the fractions of the population actively infected and still susceptible as
implied by the structural model. Our estimation reveals rich model dynamics as well
as complex IS relationships across geographic regions as well as forecast scenarios,
an empirical finding that is absent in the literature.
This paper is organized as follows. In section 2, we present the equations of a basic
SIR model and discuss the sources of data used to choose the disease parameters
governing the recovery rate and fatality rate of the disease. In section 3, we present
our procedure for matching the SIR model to empirical estimates of cumulative
deaths outlined as step 2 of our procedure. This presentation is kept general as it can
be applied to any strictly increasing and twice differentiable empirical specification
for cumulative deaths. We contrast our specification to that used by the IHME
6

For how this important issue bears on the public debate, see https://www.nytimes.
com/2020/05/20/us/coronavirus-distancing-deaths.html and https://www.medrxiv.org/content/
10.1101/2020.05.15.20103655v2.

7

modeling team. In section 4, we present our procedure for estimating our empirical
specification for the deaths data. In section 5, we report our main findings. In section
6, we conclude.

2

A Basic SIR Model:

The SIR model we use is as follows.
The population is set to N . At each moment of time, the population is divided into
four categories (states) that sum to the total population. These states are susceptible
S, infected I, resistant R , and dead D. Agents that are susceptible are at risk of
getting the disease. Agents that are infected are contagious and may pass it on to
others through some form of interaction with susceptible agents. Agents that are
resistant are not at risk of getting the disease, either because they have immunity
built up from a vaccine or from previous experience with this or similar diseases.
Likewise, those who have died from the disease are no longer at risk of getting the
disease. In this specification of the model, we assume that immunity is permanent
so that being resistant R or dead D is an absorbing state. We normalize the total
population N = 1, so all results regarding S, I, R and D should be interpreted as
fractions of the relevant population.
The initial distribution of the population across these states at time t = 0 is given
by S(0) > 0, I(0) > 0, R(0) â‰¥ 0 and D(0) â‰¥ 0. For a new disease such as COVID-19,
we assume that all agents are at risk of getting the disease, so that R(0) = D(0) = 0,
S(0) is very close to one, and I(0) is a small number corresponding either to the
initial cases of the disease transmitted to humans from some animal source (as in
Wuhan) or introduced into a country or other local geography through travel.
These fractions of the population evolve over time as follows
dS(t)/dt = âˆ’Î²(t)

8

S(t)
I(t)
1 âˆ’ D(t)

dI(t)/dt = Î²(t)

S(t)
I(t) âˆ’ Î³I(t)
1 âˆ’ D(t)

dR(t)/dt = (1 âˆ’ Î½)Î³I(t)
dD(t)/dt = Î½Î³I(t)
Since all of the parameters in these equations are positive, agents flow only in one
direction, from the state S to the state I and then to state R or D.
We treat the evolution of the population as deterministic. This may be appropriate
once the disease has infected a large number of individuals, but at the early stage
of a pandemic with a small number of infected agents, it is more appropriate to
think of the evolution of the number of infected agents as stochastic because of
the small number of these agents. We abstract from that issue here, but it is of
substantive importance if one wishes to model the dynamics of the pandemic early
on or contemplates the possibility of completely eliminating the disease (driving
I(t) from a positive number to zero). In light of our use of a deterministic model,
we focus our estimation on relatively large geographic regions and we model the
pandemic starting from an initial date t0 at which point a threshold number of 50
cumulative deaths have occurred. We then apply the model under the presumption
that the Law of Large Numbers allows this deterministic model to be an accurate
representation of the underlying stochastic evolution of the disease and we treat the
errors in our empirical specification of deaths as reporting or measurement errors.
The parameters of the model can be interpreted as follows.
The parameter Î³ governs the rate at which agents who are infected stop being
infectious and hence stop transmitting the disease. Here we model this as a transition
from the state I to the state R or D. We refer to this parameter as the recovery
rate. Because there is no cure for a viral disease such as COVID-19, this parameter
is considered a fixed parameter determined by the biology of the disease. There is a
range of estimates of this parameter Î³ taken from clinical observations of data such

9

as the length of time agents known to be infected shed the virus7 as well as data
from contact tracing determining who got sick from contact with whom.8 Estimates
for COVID-19 continue to be updated as new data comes in.9 . Values of Î³ between
1/4 and 1/14 are considered in the literature, corresponding to an infectious period
of 4 to 14 days on average. In this paper, we use Î³ = 1/5. We discuss sensitivity of
our results to this parameter below.
We denote the fatality rate from the disease by Î½. That is, Î½ is the fraction of
infected agents who stop transmitting the disease because they died.10 Measurement
of the fatality rate of the disease is difficult because of incomplete measurement of the
number of infected people and of the number of deaths from COVID-19. There is a
wide range of estimates of this parameter. Early estimates of the fatality rate among
infected people from the Diamond Princess cruise ship in which both infections and
fatalities were well measured are in the range of 1.2%.11 Recent estimates of the
infection fatality rate obtained from trends in the case fatality rate and testing data
worldwide and in the United States lie in the range of 1.0% and 1.3% respectively.12 .
The website Worldometer combines data on antibody testing and fatalities for New
York City to estimate and infection fatality rate of 1.4%.13 A number of estimates
based on antibody testing (serology studies) elsewhere imply a much lower infection
fatality rate in the range of 0.2%.14 We consider values of Î½ = 0.5% as our baseline
value and 1% as an alternative value.
7

See, for example He et al. (2020)
See, for example, Zhao et al. (2020) at https://www.medrxiv.org/content/10.1101/2020.02.21.
20026559v1 and Sanche S (2020) at https://wwwnc.cdc.gov/eid/article/26/7/20-0282 article
9
See, for example, this pre-print in Nature https://www.nature.com/articles/s41586-020-2196-x
10
For the purposes of this paper, we assume that this death rate is constant and thus independent
of the stress placed on the health care system at points of peak infection. That assumption is clearly
incorrect. Evidence from Wuhan, Italy, and New York City all suggest that case fatality rate from
COVID-19 and the overall mortality rate is much higher in periods of peak infection.
11
See https://www.medrxiv.org/content/10.1101/2020.03.05.20031773v2
12
See https://www.medrxiv.org/content/10.1101/2020.05.11.20098780v1.full.pdf and https://
www.healthaffairs.org/doi/full/10.1377/hlthaff.2020.00455
13
See https://www.worldometers.info/coronavirus/coronavirus-death-rate/
14
See https://www.medrxiv.org/content/10.1101/2020.05.13.20101253v1.full.pdf for a recent
summary of such studies.
8

10

The parameter Î²(t) is the rate at which infected agents spread the virus to (or
â€œshedâ€ the virus onto) others that they encounter at date t. We refer to this parameter as the transmission rate. This parameter is a reduced-form parameter that is
impacted by the biological disease transmission mechanism, the rate at which agents
bump into each other in the course of their daily activities, and the extent to which
agents use prophylactics in their meetings. This parameter can thus be impacted by
mitigation measures such as social distancing, hand washing, and the use of masks,
etc. This parameter is also subject to natural, or apparently random, fluctuations
over time and across space due to changes in the biological disease transmission
mechanism.15
Note in the first two equations governing the flow of agents from the state S to the
state I over time, we assume that the transmission of the disease from infected to
susceptible agents is mitigated through random and uniform matching of agents in
the population as indicated by the term S(t)/(1âˆ’D(t)) in those two equations. That
is, we interpret Î²(t) as capturing the rate at which an infected agent interacts with
and sheds virus onto agents of any kind in the population.16 Under the assumption
that the interaction of infected agents with other agents is random and uniform,
then the the rate at which an infected agent meets a susceptible agent and sheds
virus onto that agent is given by Î²(t)S(t)/(1 âˆ’ D(t)). This assumption that the
transmission of the disease is mitigated by random and uniform matching is a very
15

Seasonal influenza is an example of a disease whose transmission rate fluctuates regularly
with the weather. The Spanish Flu of 1918-19 came and went in three big waves in the Spring
and Fall of 1918 and the Spring of 1919. It is not fully understood what drove the changes over
time in the transmission rate of that disease. The available data on COVID-19 indicates that
the transmission rate varies tremendously across different geographies. See https://www.cidrap.
umn.edu/sites/default/files/public/downloads/cidrap-covid19-viewpoint-part1 0.pdf for a careful
discussion of natural fluctuation in transmission of similar diseases. See https://www.nytimes.com/
2020/05/03/world/asia/coronavirus-spread-where-why.html for a discussion of geographic variation
in transmission of COVID-19.
16
Note that in this simple model, we do not differentiate between infected agents with mild and
severe cases of the disease in terms of their role in spreading the disease. Clearly, the severity of
the disease may impact the spread, particularly since the very sick are likely to stay at home or
go to the hospital. Research is ongoing into the question of the extent to which those who are
infected but asymptomatic spread the disease. See, for example this research in Science https:
//science.sciencemag.org/content/early/2020/03/24/science.abb3221

11

stark assumption maintained here for simplicity.
The following notation is useful in presenting our results.
We define the ratio Î²(t)/Î³ to be the normalized transmission rate. It is standard
to refer to the value of the normalized transmission rate at the start of the pandemic
before any mitigation measures and use of prophylactics are undertaken as the basic
reproduction number of the disease. We denote this basic reproduction number by
R0 â‰¡ Î²(0)/Î³. This parameter corresponds to the parameter cited in many news and
academic studies.17
We refer to the term R(t) as the effective reproduction number of the disease
at date t. This effective reproduction number is the ratio of the rate at which
infected agents infect susceptible agents to the recovery rate of infected agents from
the disease at date t when the the pandemic has progressed for some time. In the
model, we assume that the effective reproduction number of the disease is given
by the product of the normalized transmission rate and the fraction of agents who
remain susceptible to the disease, R(t) = (Î²(t)/Î³)S(t)/(1 âˆ’ D(t)). Thus, in the
model, the effective reproduction number of the disease can differ from the basic
reproduction number for two reasons. First, as discussed above, the normalized
transmission rate Î²(t)/Î³ may vary over time with changes in the transmission rate
Î²(t), either due to steps undertaken to mitigate the transmission rate of the disease
or through naturally occurring changes in the transmission of the disease. Second,
the effective reproduction number falls as the fraction of agents remaining susceptible
to the disease S(t)/(1 âˆ’ D(t)) falls.
With this notation, we can restate the equations of the model in terms of the
effective reproduction number as
dS(t)/dt = âˆ’R(t)Î³I(t)

17

(1)

The use of the notation R0 to denote the basic reproduction number and the letter R to denote
the fraction of agents who are resistant is an unfortunate choice of notation, but it is standard. See
for example https://mathworld.wolfram.com/Kermack-McKendrickModel.html

12

3

dI(t)/dt = (R(t) âˆ’ 1) Î³I(t)

(2)

dR(t)/dt = (1 âˆ’ Î½)Î³I(t)

(3)

dD(t)/dt = Î½Î³I

(4)

Model Estimation and Identification Strategy

In this section we provide an overview of our strategy for estimating our SIR model
given an empirical specification for the data on cumulative deaths and we discuss
which model parameters are identified in our procedure.
To understand our procedure for estimating our SIR model, consider the following
thought experiment. Assume that we have complete data on cumulative deaths D(t)
in some region from dates t = t0 to T , where t0 is the calendar date on which
cumulative deaths Dt0 are equal to some threshold (we use 50) and T represents the
current period. Assume that we also have data on the first and second derivatives
of cumulative deaths during this time period. These derivatives are continuous time
versions of data on daily deaths and the change in daily deaths. Assume that we do
not have data on the number of agents with active infections or who are resistant.
Consider the following thought experiment based on these assumptions. Imagine
that we fix parameters Î½ and Î³ governing the fatality rate and recovery rate of the
disease. What state of the population at date t0 , S(t0 ), I(t0 ), R(t0 ) and D(t0 ) and
course of the time-varying normalized transmission rate Î²(t)/Î³ from dates t0 to T
would allow the model to match exactly the data on deaths from t0 to T ?
We have the following equations to work with in estimating these additional parameters of the model. Note that we assume that these equations apply for all t > 0

13

but we only have data on the level and derivatives of cumulative deaths from t â‰¥ t0 .
From (4), we have
1
dD(t)/dt
I(t) =
Î½Î³
Using (3) and (4) together and the assumption that R(0) = D(0) = 0, we have that
R(t) =

1âˆ’Î½
D(t)
Î½

Using that the states must sum to one, we have
1
1 dD(t)
S(t) = 1 âˆ’ D(t) âˆ’
.
Î½
Î½Î³ dt
These equations then give the full path of the state of the population from dates t0 to
T . Note that the intuition behind these equations is straightforward. To determine
the number of resistant agents at time t, we simply use the observation that level
of cumulative deaths together with an estimate of the fatality rate of the disease
tells us how many agents are resistant to the disease. To determine the number of
actively infected agents at time t, we use the observation that the level of daily deaths
(the derivative of cumulative deaths) together with an estimate of the fatality and
recovery rates of the disease tells us the number of active infections. The number of
susceptible agents at time t is then one minus these two quantities.
One can measure the effective reproduction number from the growth rate of deaths
as follows. From equation (2), the evolution of the true number of infected agents is
given by
Z
t

(R(s) âˆ’ 1)ds)

I(t) = I(0) exp(Î³
0

From equation (4), we then have that
dD(t)
= Î½Î³I(0) exp(Î³
dt

Z

t

(R(s) âˆ’ 1)ds)
0

where this time derivative of deaths is approximated in the data by the daily number

14

of new deaths. If we differentiate this expression again, we get
d2 D(t)
= Î½Î³ 2 I(0) exp(Î³
dt2

Z

t

(R(s) âˆ’ 1)ds)(R(t) âˆ’ 1)
0

Thus, we can get an estimate of the effective reproduction number of the disease at
time t from18
d2 D(t)
1 dt2
R(t) = 1 + dD(t)
(5)
Î³
dt

To recover the implied path of the normalized transmission rate, note that equation
(5) together with the death data gives the following estimate for the path of the
product of the effective reproduction between dates t0 and T . This estimate together
with the estimate of S(t) above imply that the normalized transmission rate Î²(t)/Î³ =
R(t)(1 âˆ’ D(t))/S(t) needed to match the deaths data exactly for t âˆˆ [t0 , T ] is given
by
1
Î³

1+
Î²(t)
=
Î³
1 âˆ’ Î½1 D(t) âˆ’

d2 D(t)
dt2
dD(t)
dt

(1
1
dD(t)/dt
Î½Î³

âˆ’ D(t))

This estimation procedure makes clear the identification problem in pinning down
the parameters Î½ and Î³ from deaths data alone. In particular, if we start with a prior
for Î½ and Î³, we should not be able to update this prior based on deaths data alone
unless the estimates above result in inadmissable values of implied I(t), R(t) or S(t)
(above 1 or negative) or some implausible path for the normalized transmission rate
Î²(t)/Î³ (negative).
To implement this estimation of the SIR model, one must construct an empirical
estimate of the data on cumulative deaths and the first and second derivatives of
cumulative deaths. It is here that our method makes contact with widely noted
reduced-form approaches to estimating the progression of the COVID-19 pandemic.
To illustrate this connection, we discuss the reduced form approach developed by
researchers at the Institute for Health Metrics and Evaluation (IHME) at the Uni18

Thanks to James Stock for pointing out this calculation.

15

versity of Washington.19
We focus on the estimation of the IHME model using data on cumulative deaths.
The simplest version of this model assumes that the path of cumulative daily deaths
from some initial calendar date t0 on is given by
p
D(t) =
2

2
1+ âˆš
Ï€

Z

!

a(tâˆ’t0 âˆ’b)

exp(âˆ’Ï„ 2 )dÏ„

0

where the parameter p denotes the limiting number of deaths Dâˆž , a is a growth
parameter, and b is an inflection point. This specification produces an implication
for daily deaths (approximated by the derivative of cumulative deaths) given by
pa
dD(t)
= âˆš exp(âˆ’a2 (t âˆ’ t0 âˆ’ b)2 )
dt
Ï€
that peaks at time t = b + t0 and then falls thereafter. Note that the implied growth
rate of the logarithm of daily deaths is given by
d2 D(t)
dt2
dD(t)
dt

= 2a2 (b + t0 âˆ’ t).

The model is fit to the available data on deaths between the initial date t0 and the
current date, and then the assumed parametric form is used to project daily deaths
beyond the current date. This projection is based on the claim that this parametric
form fits the data for locations that are further along in disease progression. One
can incorporate measures of the extent and timing of mitigation in the estimation as
covariates for the parameters p and b based on experience across locations.
If, as our model implies with a constant fatality rate Î½, observed deaths are related
19

See the working paper discussion of the IMHE forecasting model here http://www.healthdata.
org/sites/default/files/files/Projects/COVID/RA COVID-forecasting-USA-EEA 042120.pdf
See also a similar model developed at the University of Texas-Austin at https:
//covid-19.tacc.utexas.edu/media/filer public/87/63/87635a46-b060-4b5b-a3a5-1b31ab8e0bc6/
ut covid-19 mortality forecasting model latest.pdf

16

to active infections by equation (4), then equation (5) implies that the path of the
effective reproduction number over time implied by the parameters of this empirical
specification for cumulative deaths is given by
R(t) = 1 âˆ’

2a2
(t âˆ’ t0 âˆ’ b)
Î³

That is, for our SIR model to replicate this pattern of cumulative deaths, the normalized transmission rate Î²(t)/Î³ would have to vary over time so as to produce the path
for the effective reproduction number R(t) = (Î²(t)/Î³)S(t)/(1 âˆ’ D(t) given above.
Note then that this empirical specification implies that the effective reproduction
number falls linearly over time, not only in the period of estimation, but also going
forward beyond the current period.20 Thus, in the context of a structural model,
unless one assumes that the current value of S(t)/(1 âˆ’ D(t) is substantially below
one, this is equivalent to assuming that the impact of mitigation measures on disease
transmission will continue to lower the transmission rate over time rather than keep
it stable at current levels or even allow it to rise. It is not clear that this is a natural
assumption regarding the impact of lockdowns or other disease mitigation measures
â€” that their impact on disease transmission would grow over time.
The empirical specification for the deaths data that we use is considerably more
flexible than that used in the IHME model in that it is based on Weibull functions. In
the simplest version of our specification (with one regime), the data on daily deaths
is modeled as
" 
bâˆ’1

b !#
b t âˆ’ t0 âˆ’ c
t âˆ’ t0 âˆ’ c
dD(t)
=d
exp âˆ’
dt
a
a
a
where the parameter a > 0 is the scale parameter, b > 0 is the slope parameter, and
c is the location parameter of a Weibull density, while d > 0 allows us to scale this
20

Clearly, at some point, this implied effective reproduction number becomes negative, which is
inadmissable. This observation implies that this functional form for cumulative deaths cannot be
reproduced by our SIR model with any set of parameters and time varying transmission rate Î²(t).

17

density function up or down to integrate to d. The implied effective reproduction
number is
"

bâˆ’1 #
1
bâˆ’1
b t âˆ’ t0 âˆ’ c
R(t) = 1 +
âˆ’
Î³ t âˆ’ t0 âˆ’ c a
a
This prediction for the effective reproduction number given our empirical specification for daily deaths can take on various shapes parameterized by a, b, and c. In
particular, with b = 1, the Weibull function implies a constant path for the effective
reproduction number. With b < 1, the implied effective reproduction number rises
over time. With b > 1 it falls over time. This critical dependence on the parameter
b corresponds to the properties of the density of the Weibull distribution here representing the pattern of daily deaths itself. With b = 1, daily deaths start at t = t0
at a constant value and decline monotonically as t increases. With b > 1 and c = 0,
daily deaths approach zero as t approaches t0 , but the implied effective reproduction
number approaches infinity. With a large enough value of b (say 4), this function
produces a hump-shaped pattern of daily deaths. Setting c > 0 with b > 1 allows
for a finite implied effective reproduction number at t = t0 .

4

Empirical Implementation of the Model for Daily
Deaths

In this section we describe and estimate the empirical model that we use for daily
deaths.
Consider a mixture of Weibull functions:
(
" 

bi âˆ’1
bi #)
I
X
bi t âˆ’ t0 âˆ’ ci
t âˆ’ t0 âˆ’ ci
dDt
=
wi (t) di
exp âˆ’
,
dt
ai
ai
ai
i=1

(6)

where ai > 0 is the scale parameter, bi > 0 is the slope parameter, ci < t âˆ’ t0
is the location parameter, di > 0 is the height parameter, the weight parameter

18

wi (t) is positive for all i and t, I is a positive integer indicating the number of
P
mixtures, and Ii=1 wi (t) = 1. The term in the curly bracket on the right-hand side
of equation (6) is the three-parameter Weibull distribution density function scaled
by di . In the I = 2 case, we set, w1 (t) = eâˆ’s(tâˆ’m) /(1 + eâˆ’s(tâˆ’m) ), where s is the
steepness parameter and the parameter m represents the sigmoidâ€™s midpoint.
Let âˆ†DtData be the measured object for dDt /dt and denote


Data
Data
âˆ†Dt, Data â‰¡ âˆ†DtData , âˆ†Dtâˆ’1
, âˆ†Dtâˆ’2
, . . . , âˆ†DData â‰¡ âˆ†DtData
, Â· Â· Â· , DTData .
0
Given the discrete-time data, we approximate continuous-time equation (6) by first
estimating the non-linear regime-switching equation
âˆ†DtData =

2
X
i=1

(

bi
wi (t) di
ai



t âˆ’ t0 âˆ’ ci
ai

bi âˆ’1

" 
b #)
t âˆ’ t0 âˆ’ ci i
exp âˆ’
+ Ïƒkt Îµt , (7)
ai

where Îµt is a state-dependent standard normal random residual. The switching state
kt âˆˆ {1, . . . , K} can accommodate both an expectedly large surge in daily deaths
and a low death volatility typically associated with a low number of deaths. Since
the first term on the right-hand side of equation (7) can be very large for some
t, moreover, negative values of Îµt allow for actual daily deaths substantially lower
than the value implied by the first term on the right-hand side of equation (7). The
k
] for kt is unrestricted except that each column of Qk
transition matrix Qk = [qi,j
sums to one. For our deterministic SIR model to offer an accurate account of health
consequences of the pandemic, we set t0 at the time when the number of deaths
accumulates to 50.
Denote a collection of the parameters by

k
Î¸ = s, m, a1 , b1 , c1 , d1 , a2 , b2 , c2 , d2 , Ïƒ1 , Â· Â· Â· , ÏƒK , qi,j
.
From equation (7) one can derive the (log) conditional likelihood function for âˆ†Dt, Data

19

as

log L âˆ†DtData | âˆ†Dtâˆ’1, Data , kt , Î¸ =
T
X
T âˆ’ t0
log L
| kt , Î¸ = âˆ’
log(2Ï€) âˆ’
log(Ïƒkt )
2
t=t0


 

bi âˆ’1
bi 2
PI
bi
tâˆ’t0 âˆ’ci
tâˆ’t0 âˆ’ci
Data
âˆ†Dt
âˆ’ i=1 wi (t) di ai
exp âˆ’
T
ai
ai
X

âˆ†DtData

âˆ’



2Ïƒk2t

t=t0

. (8)

It follows that the likelihood function for âˆ†DData is

L âˆ†DData | Î¸ =
T X
K
Y




L âˆ†DtData | âˆ†Dtâˆ’1, Data , kt , Î¸ p kt | âˆ†Dtâˆ’1, Data , Î¸ . (9)

t=t0 kt =1


Given the initial condition p kt0 âˆ’1 = 1 | âˆ†Dt0 âˆ’1, Data , Î¸ = 1/K, the predictive prob
ability of regime, p kt | âˆ†Dtâˆ’1, Data , Î¸ , can be updated recursively through Hamilton
(1989)â€™s filter as
p kt | âˆ†D

tâˆ’1, Data



,Î¸ =

K
X

qkt ,ktâˆ’1 p ktâˆ’1 | âˆ†Dtâˆ’1, Data , Î¸



(10)

ktâˆ’1 =1

and

p kt | âˆ†Dt, Data , Î¸ =


L âˆ†DtData | âˆ†Dtâˆ’1, Data , kt , Î¸ p kt | âˆ†Dtâˆ’1, Data , Î¸
PK

kt =1

[L (âˆ†DtData | âˆ†Dtâˆ’1, Data , kt , Î¸) p (kt | âˆ†Dtâˆ’1, Data , Î¸)]

. (11)

Let p(Î¸) be the prior pdf. Specifically, we take p(Î¸) to be the Gamma distribution
for ai , bi , di , s, and m, the uniform distribution for ci and Ïƒkt ,21 and the Dirichlet
21

The linear regression literature only uses the inverse Gamma distribution for Ïƒkt as conjugate

20

distribution for the elements of Qk . It follows that the log posterior density function
of Î¸ is



log p Î¸ | âˆ†DData = log L âˆ†DData | Î¸ + log p(Î¸) âˆ’ log p âˆ†DData ,

(12)


where p âˆ†DData is the marginal data density (MDD). For each case (i.e., state,
Census region, or country), we use the MDD to select the number of mixtures, I.

5

Findings

The data sources for daily deaths are New York Times for U.S. states and regions
and Johns Hopkins University for other countries. We do not smooth the data with
a preset filter but rather estimate the death pattern using the Bayesian procedure
presented in Section 4. The estimation enables us to incorporate the uncertainty
about deaths into our structural model.
We present estimates, forecasts, and counterfactual exercises for ten large U.S.
states, nine U.S. Census Regions, and a number of additional countries. The ten
states we consider are New York, New Jersey, Massachusetts, Michigan, Pennsyvania, Illinois, California, Connecticut, Louisiana and Maryland. The Census Regions
are South Atlantic, East North Central, Mountain, West North Central, West South
Central, Pacific, and New England. The additional countries that we consider are
the United Kingdom, Italy, France, Spain, Brazil, Belgium, Germany, Iran, Mexico,
Canada, Netherlands, Sweden India, Peru, Russia, and Switzerland. The presentation is ordered from most deaths to least deaths on May 21, 2020 first for states,
then for Census regions, and finally for countries.
For each region, we start the estimation at a region specific date t0 at which
prior. For our nonlinear regression here, the inverse Gamma prior is no longer conjugate. Moreover,
since the death data implies that the values of Ïƒkt are far less than one, the inverse Gamma prior
only with no moments can cover such small values. This makes the inverse Gamma prior not only
undesirable but also unpractical.

21

cumulative deaths first reach 50 and let T denote the number of days in the estimation
period. We then present forecast and counterfactual scenarios for an additional time
period equal to twice the number of days in the estimation period (2T ).
We consider two forecast scenarios for each state, region, or country. In the first
forecast scenario, we set the normalized transmission rate to Î²t /Î³ = 2 from the end
of the estimation period to the end of the forecast period. In the second forecast
scenario, we set the normalized transmission rate to Î²t /Î³ = 1.3 from the end of the
estimation period to the end of the forecast period.
To construct counterfactual scenarios, we shift the estimated/forecast path for the
normalized transmission rate Î²(t)/Î³ back by seven days and fill in the first seven days
of this counterfactual path for the transmission rate of the disease with its initial
value Î²(0)/Î³. That is, the counterfactual path for the normalized transmission rate
is given by Î²Ìƒ(t + 7)/Î³ = Î²(t)/Î³ for t â‰¥ 0 and Î²Ìƒ(s)/Î³ = Î²(0)/Î³ for 0 â‰¤ s < 7. Note
that this shift is for both the estimation and forecast period. Thus, there are two
counterfactual scenarios for each state, region, or country, corresponding to the two
forecast scenarios outlined above. We interpret this shift as corresponding to a oneweek delay in the imposition and relaxation of mitigation measures. Mechanically,
given our estimation of a rapidly declining effective reproduction number early on in
the estimation period in nearly all regions, this counterfactual corresponds to adding
a week of rapid transmission of the disease after the region reaches 50 cumulative
deaths beyond what actually occurred.
We present our results in a collection of tables and figures below.

5.1

Organization of the figures and tables

For each state, census region, and country considered, we present our estimation,
forecast, and counterfactual results in a collection of four figures.
In each case, the first figure, with two panels, shows the data on daily and cumu-

22

lative deaths over the estimation period with the estimated Weibull specification for
daily and cumulative deaths.
The second figure, also with two panels, shows our estimated and forecast paths
for daily and cumulative deaths under the two forecast scenarios that we consider.
The normalized transmission rate after the estimation period is set to 1.3 for the
first forecast scenario (blue curve) and 2 for the second forecast scenario (red curve),
except for West South Central where the normalized transmission rate is set to 1.9
for the second forecast scenario.
The third figure has six panels that shows other model outcomes for the estimation and forecast period under the two forecast scenarios. These are the effective
reproduction number, the normalized transmission rate, the fraction of the population remaining susceptible, the fraction actively infected, the fraction resistant,
and the change in daily deaths (the second derivative of our empirical specification
for cumulative deaths). Outcomes under the forecast scenario with the normalized
transmission rate set to 1.3 after the estimation period are shown in blue and with
the normalized transmission rate set to 2 after the estimation period are shown in
red.
The fourth figure also has six panels. These panels show six model outcomes for
the estimation and forecast periods under our counterfactual scenarios. These are
the effective reproduction number, the fraction remaining susceptible, daily deaths,
cumulative deaths, the normalized transmission rate (the counterfactual), and the
fraction of the population actively infected.
In tables 1 and 2, we summarize the results of our counterfactual experiments
across states and census regions (table 1) and countries (table 2) by showing the
number of cumulative deaths at the end of the forecast period for the two baseline
and counterfactual scenarios (normalized transmission rates for the forecast period
equal to 1.3 and 2 respectively).
In tables 3 and 4 we show how the change in the effective reproduction number

23

over the estimation period for New York and the United Kingdom is decomposed
into a change in the normalized transmission rate and a change in the fraction of
agents still susceptible to the disease.

5.2

Key Findings

Consider our key findings.

5.2.1

Decline in the transmission of the disease in the estimation period

Across almost all regions and countries that we consider, the growth of the pandemic,
as measured by its effective reproduction number, has fallen dramatically from the
initial date at which cumulative deaths reached 50 to the present (the end of the
estimation period marked by a vertical line in the figures). In many cases, we see
declines of the effective reproduction number from levels well above 3 to levels well
below 1.
In almost all regions, we see that the decline in the effective reproduction number
has occurred primarily through a reduction in the normalized transmission rate rather
than through a decline in the fraction of the population remaining susceptible to the
disease. We illustrate this point in greater detail in Tables 3 and 4.
This rapid decline in the effective reproduction number of the disease seen in the
regions that we consider accounts for the observation that infections and deaths have
not reached the levels that were forecast by some in mid March. In fact, across the
regions that we study, we see within the estimation period a clear first wave in terms
of daily deaths â€” these have peaked and begun to decline rather than continue to
grow to very high levels.
Our estimation also indicates that in almost all states, Census regions, and countries, the fraction of the population that remains susceptible to the disease is still
quite high and the fraction of the population with active infections, while not ex24

traordinarily high, is considerably higher than it was in mid-March. These findings
regarding the current distribution of the population across the states S, I, R, and
D then play an important role in shaping our forecast scenarios.

5.2.2

Forecast scenarios

Our two forecast scenarios for the normalized transmission rate of the disease going forward (1.3 in blue and 2 in red) correspond to normalized transmission rates
seen in many states, regions, and countries late and early in the estimation period
respectively. We see in our forecast scenarios in red with a normalized transmission
rate of 2, the threat of a severe second wave of infections and daily deaths that in
many cases is much larger than the first wave (in New York these are of roughly
equal size). In this second forecast scenario, this large second wave would be over
in about 100 days from the end of the estimation period. In most cases, under our
forecast scenario with the normalized transmission rate set to 1.3, we also have a
second wave of daily deaths and infections, but this second wave is milder and lasts
longer. These forecast scenarios of a second wave are driven by our estimates that
the fraction of the population that remains susceptible to the disease is very high in
almost all regions and the fraction of the population that is actively infected, while
not extraordinarily high, is substantially larger than it was in early March.
In terms of the cumulative burden of the disease, we see that these two forecast
scenarios have dramatically different implications for cumulative deaths at the end of
the forecast period. In each case, the forecast scenario with the normalized transmission rate at 2 results in substantially more daily deaths than that with the normalized
transmission rate at 1.3. To see this point, compare the cumulative deaths reported
in tables 1 and 2 under the columns labeled baseline scenario 1 (with normalized
transmission rate 1.3) and baseline scenario 2 (with normalized transmission rate 2).
It remains to be seen whether it will be possible to keep the normalized transmission rate as low as considered in our blue scenario for the next 100 days or so. Note
that the fraction of agents still susceptible under this milder scenario remains high
25

at the end of the forecast period in many regions. This observation implies that,
under this scenario, regions that did succeed in keeping the normalized transmission
rate low for the next 100 days or more would still be vulnerable to a large increase
in daily deaths and infections were the transmission rate to rise substantially above
1.3 after the end of the forecast period.

5.3

Counterfactuals

Perhaps most interesting are our counterfactual results regarding the implications
for changes in the timing of mitigation of disease transmission on the cumulative
number of deaths from the disease over the long run. Recall that we consider a
counterfactual scenario under which the path of the normalized transmission rate
through time is pushed back seven days in both the estimation and forecast period.
Because we have two forecast scenarios, we thus have two counterfactual scenarios
as well, corresponding to the assumed path of the normalized transmission rate after
the estimation period. Results on counterfactual model outcomes including active
infections and daily deaths for both the estimation and forecast periods are shown in
the fourth figure for each state, Census region, and country. Recall that the vertical
lines in these figures mark the end of the estimation period. Results on cumulative
deaths at the end of the forecast period under these two counterfactual scenarios are
reported in tables 1 and 2 for each state, Census region, and country.
One can see in the lower left panel (first panel of the third row) of the fourth
figure for each state, Census region, and country, the counterfactual normalized
transmission rate considered, with that in the scenario corresponding to a normalized transmission rate in the forecast period of 1.3 shown in blue and that with a
normalized transmission rate of 2 in the forecast period shown in red. In each of
these figures, one can see the small flat portion at the start of the estimation period
which is where we are assuming that rapid transmission of the disease would have
continued for seven days after the region first reached the threshold of 50 deaths.

26

We report on the counterfactual paths of daily deaths in the first panel of the
second row and on active infections in the second panel of the third row of this
figure of counterfactual outcomes. In many regions, the counterfactual paths for the
normalized transmission rate result in a significantly larger first peak of daily deaths
and infections in the estimation period. This finding confirms the common wisdom
that delayed mitigation of the disease in this early phase of the pandemic would have
resulted in a more severe first wave than actually occurred. Corresponding to this
observation, this counterfactual also typically results in a significantly larger number
of cumulative deaths (shown in the second panel of the second row) at the end of
the estimation period than actually occurred.
But what do these counterfactual scenarios imply for the cumulative number of
deaths in the longer run at the end of the forecast period? Here the results can
go either way â€” a seven day delay in the reduction (and subsequent increase) in
the normalized transmission rate can result in either an increase or a decline in the
number of cumulative deaths at the end of the forecast period.
This finding can be seen most clearly in tables 1 and 2. For New York, we see that
the counterfactual number of cumulative deaths at the end of the forecast period
is either substantially or mildly larger than that under the baseline paths for the
normalized transmission rate. For California, we see that the counterfactual outcomes for cumulative deaths at the end of the forecast period hardly differ from the
baseline.
But this is not always the case. For Pennsylvania, and for the aggregate for the
United States, we see that the counterfactual number of cumulative deaths at the
end of the forecast period under the scenario with a normalized transmission rate
equal to 2 during the forecast period is actually lower than the baseline number, and
for Pennsylvania in particular this difference is quite large. We see the same result
that the counterfactual cumulative deaths at the end of the forecast period are lower
than the baseline cumulative deaths under scenario 2 for Italy, Brazil, Iran, Canada,
and Switzerland.

27

How should one understand this result? Here, as suggested by Rachel (2020),
examination of the phase diagram of the model is quite useful for building intuition
for this result. We show such a phase diagram for our two baseline and counterfactual
scenarios in the case of Pennsylvania in figure 24. Each of the two panels of this figure
show the model outcomes for S(t) on the x-axis and I(t) on the y-axis in the first
scenario (with the normalized transmission rate after the estimation period set to
1.3) on the left and in the second scenario (with the normalized transmission rate
set to 2) on the right. There is a vertical line in each figure marking the point of
herd immunity once the normalized transmission rate reaches it long run value. For
the first scenario, this is at S = 1/1.3. For the second scenario, this is at S = 1/2.
One can use this figure to understand the model dynamics as follows. The model
outcomes start at S(t0 ) very close to one and I(t0 ) very small at the extreme lower
right part of the panel. The long run outcome for S(t) as t gets very large must
occur at a point to the left of the vertical line in the panel â€” in the long-run, active
infections do not decline unless the population has herd immunity relative to the
long-run value of the normalized transmission rate marked by the vertical line in the
figure.
But exactly how far to the left of the vertical line marking herd immunity the
fraction of the population that is susceptible at the end of the pandemic lands when
infections shrink to zero depends on what fraction of agents are actively infected at
the moment in the forecast period that the population reaches that point of herd
immunity. If that fraction is high, then it will take a long time for the number of
active infections to decline to zero and many more susceptible agents will be infected
in the long run. If that fraction is low, then, the remaining active infections will die
out quickly and the fraction of agents remaining susceptible in the long run will end
up close to the line marking herd immunity. Counterfactual changes in the timing
of mitigation as represented by a delay in the decline of the normalized transmission
rate can thus raise or lower the long run burden of the disease, measured as one minus
the fraction of susceptible agents left in the long run, depending on the impact of
these changes on the fraction of agents actively infected when the population reaches
28

herd immunity in the forecast period.
Consider first the left panel in figure 24 showing the evolution of S(t) and I(t) for
Pennsylvania in our baseline and counterfactual scenarios in which the normalized
transmission rate is 1.3 during the forecast period. In this case, in the baseline
scenario, the early decline in the effective reproduction number as estimated implied
that the fraction of agents still susceptible at the end of the estimation period is
above that needed to achieve herd immunity in the forecast period (1/1.3). Thus, in
the forecast period, we see a second wave in the solid black line, as infections rise,
reach herd immunity, and then fall. In contrast, under the counterfactual for this
scenario, the seven-day delay in initial decline in the transmission of the disease leads
to a very large first wave of infections â€” so large that infections are very high at
the point at which they start to decline in the forecast period due to herd immunity.
Thus, in this counterfactual scenario as shown by the dotted pink line, the long run
fraction of the population that is still susceptible is quite a bit smaller than under
the baseline scenario, resulting in a substantial increase in the long-run number of
deaths.
But now consider the right panel in figure 24. This panel shows the evolution of
S(t) and I(t) for Pennsylvania in our baseline and counterfactual scenarios in which
the normalized transmission rate is 2 during the forecast period. In this case, the
ordering for cumulative long-run deaths is reversed. Under the baseline scenario
shown in the solid black line, the first wave of the pandemic is very small. Thus,
when the second wave builds during the forecast period, it builds to a high level of
active infections at the point at which the population hits herd immunity, and the
fraction of the population that remains susceptible in the long run is very low. In
contrast, under the counterfactual scenario in this case, because the first wave of the
pandemic is larger, the population actually reaches herd immunity before the end of
the estimation period and active infections at the start of the forecast period are so
low that the pandemic dies out very quickly once that period starts. Thus, in this
case, a delay in mitigation leading to a larger first wave of infections leads, in the
long run, to a smaller cumulative death toll.
29

One can see how these rich model dynamics make it very difficult to draw firm
conclusions about the impact of changes in the timing of mitigation measures on the
long run cumulative death toll by considering alternative counterfactual scenarios
with a shorter delay of mitigation of 5 days (shown in figure 25) and a longer delay
of mitigation of 14 days (shown in figure 27). In the left panel of figure 25, we see
that a five day delay of mitigation would have had no impact on cumulative deaths
if the normalized transmission rate was 1.3 in the forecast period, while in the right
panel of that figure, we see that the five day delay would again have been helpful in
reducing the cumulative death toll. In contrast, in figure 27, we see that a 14 day
delay in mitigation would have resulted in an increase in the cumulative death toll
under both scenarios for the normalized transmission rate during the forecast period.

5.4

Uncertainty bands

We simulate 100, 000 random draws from the posterior probability distribution p Î¸ | âˆ†DData
and use these draws to generate 68% probability bands of various SIR model variables as they provide an informative description of the posterior shape (Sims and
Zha, 1999).22 Using Pennsylvania as an example, we report these uncertainty bands
in figures 21, 22, and 23. As one can see from the left panel of figure 21, the posterior
distribution is skewed. During April 22-28, for instance, the posterior mode (the solid
line) is outside and above the 68% probability bands, indicating that the posterior
distribution is skewed downward to reflect the sudden drops in daily deaths. During
May 6-10, the posterior mode is below the 68% probability bands, indicating that
the posterior distribution is skewed upward to reflect a large rise in daily deaths. For
cumulative deaths, the 68% probability bands contain the actual observations (right
panel of figure 21).
The left panel of figure 22 displays 68% probability bands of daily deaths under
our two scenarios of the normalized transmission rate. After cumulating these daily
22

On our standard modern desktop, this whole computation process takes about 192 minutes.
The program is coded up in a combination of C++ and Matlab.

30



deaths, the right panel of the figure shows a large degree of uncertainty about the
total death toll. This uncertainty can be explained by figure 23, which shows that
the posterior distribution for the normalized transmission rate is skewed downward
during the 25-day period around the end of the sample because the mode estimate
is above the 68% probability bands for both forecast scenarios. As a result, the
68% probability bands for the effective reproduction number stay below the mode
estimate during the same period, even though there is more probability assigned
to larger values of S(t)/N (t) than the mode estimate. A majority of the posterior
probability of Rt below the mode estimate explains a large probability of daily and
cumulative deaths that stay below the mode estimate at the beginning of the forecast
period.

6

Conclusion

In this paper, we have presented a method for estimating a structural SIR model
of the COVID-19 pandemic that shares the flexibility of reduced-form models of the
evolution of this pandemic with a structural model for forecasting and counterfactual
exercises. Our Bayesian approach allows us to not only quantify the uncertainty in
our estimates, but also to model the impact of that uncertainty on our forecasts and
counterfactual exercises.
We have estimated the model and used it to construct forecast and counterfactual
scenarios for ten large states, nine Census regions, and a number of other countries.
In further work, we plan to update, on a regular basis, our estimates and forecast
and counterfactual scenarios along with uncertainty bands.

31

References
Andrew Atkeson. How deadly is COVID-19? Understanding the difficulties with
estimation of its fatality rate. Staff Report 598, Federal Reserve Bank of Minneapolis,
March 2020.
Gerado Chowell, Hiroshi Nishiura, and Luis M.A. Bettencourt. Comparative estimation of the reproduction number for pandemic influenza from daily case notification
data. Journal of the Royal Society Interface, 4(2):155â€“166, Feb 22 2007.
Anne Cori, Neil M Ferguson, Christophe Fraser, and Simon Cauchemez. A new
framework and software to estimate time-varying reproduction numbers during epidemics. American Journal of Epidemiology, 178(9), 2013.
Jesus Fernandez-Villaverde and Charles I. Jones. Estimating and simulating a SIRD
model of COVID-19 for many countries, states, and cities. Working Paper 27128,
NBER, April 2020.
James D. Hamilton. A new approach to the economic analysis of nonstationary time
series and the business cycle. Econometrica, 57(2):357â€“384, 1989.
Xi He, Eric H. Y. Lau, Peng Wu, Xilong Deng, Jian Wang, Xinxin Hao, Yiu Chung
Lau, Jessica Y. Wong, Yujuan Guan, Xinghua Tan, Xiaoneng Mo, Yanqing Chen,
Baolin Liao, Weilie Chen, Fengyu Hu, Qing Zhang, Mingqiu Zhong, Yanrong Wu,
Lingzhai Zhao, Fuchun Zhang, Benjamin J. Cowling, Fang Li, and Gabriel M.
Leung. Temporal dynamics in viral shedding and transmissibility of covid-19.
Nature Medicine, 26(5):672â€“675, 2020. doi: 10.1038/s41591-020-0869-5. URL
https://doi.org/10.1038/s41591-020-0869-5.
Ivan Korolev. Identification and estimation of the seird epidemic model for covid-19.
April 2020.
Oliver Linton. When will the COVID-19 pandemic peak? Technical Report 2020/11,
Cambridge-INET Working Paper Series, April 2020.
32

Jose Lourenco, Robert Paton, Mahan Ghafari, Moritz Kraemer, Craig Thompson,
Peter Simmonds, Paul Klenerman, and Sunetra Gupta. Fundamental principles of
epidemic spread highlight the immediate need for large-scale serological surveys to
assess the stage of the SARS-COV-2 epidemic. Cold Spring Harbor Laboratory Press,
March 26 2020.
Lucasz Rachel. An analytical model of COVID-19 lockdowns. May 2020.
Xu C Romero-Severson E Hengartner N Ke R. Sanche S, Lin YT. High contagiousness
and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerging
Infectious Diseases, 26, July 2020.
Christopher A. Sims and Tao Zha. Error bands for impulse responses. Econometrica,
67(5):1113â€“1155, 1999.
James H. Stock. Data gaps and the policy response to the novel coronavirus. Working
Paper 26902, NBER, March 2020.
Alexis Akira Toda. Susceptible-infected-recovered (SIR) dynamics of COVID-19 and
economic impact. Technical report, Cornell University, March 25 2020.
Jacco Wallinga and Marc Lipsitch. How generation intervals shape the relationship
between growth rates and reproductive numbers. Proceedings of the Royal Society
London B, (274):599â€“604, November 2006.
Jacco Wallinga and Peter Teunis. Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures. American Journal of
Epidemiology, 160(6):509â€“516, September 2004.
Shi Zhao, Daozhou Gao, Zian Zhuang, Marc Chong, Yongli Cai, Jinjun Ran, Peihua
Cao, Kai Wang, Yijun Lou, Weiming Wang, Lin Yang, Daihai He, and Maggie Wang.
Estimating the serial interval of the novel coronavirus disease (covid-19): A statistical
analysis using the public data in hong kong from january 16 to february 15, 2020.
February 2020.

33

Table 1: Cumulative deaths at the end of the forecast period in the U.S.

New York
New Jersey
Massachusetts
Michigan
Pennsylvania
Illinois
California
Connecticut
Louisiana
Maryland
South Atlantic
East North Central
Mountain
West North Central
West South Central
East South Central
Pacific
New England
United States

Forecast scenario 1
Baseline Counterfactual
30445
69813
13330
31665
11012
29687
12913
29253
24091
32129
22053
34844
65520
64554
5943
11227
6500
6247
9618
9282
26493
26624
33264
33430
21224
19395
97385
87613
43001
41894
46055
51710
602546
1129696
5644
5750
1046592
1645000

Forecast scenario 2
Baseline Counterfactual
65121
69820
30515
31670
24943
29687
37919
29298
49266
34976
48792
35216
156294
153612
12652
11250
17476
16445
23304
21790
75837
75014
84574
83210
53254
51699
235799
206431
94255
92832
137284
135278
1223241
1129868
17200
15943
2322605
2154219

Notes: The forecast period is twice the length of the sample. United States is the
sum of all the states and Census regions in the table, which excludes Guam, Virgin
Islands, and Puerto Rico.

34

Table 2: Cumulative deaths at the end of the forecast period in other countries

U.K.
Italy
France
Spain
Brazil
Belgium
Germany
Iran
Mexico
Canada
Netherlands
Sweden
India
Peru
Russia
Switzerland

Forecast scenario 1
Baseline Counterfactual
115956
286394
92459
148948
89300
319872
52443
216733
405437
459211
9496
57065
19365
376174
151722
255019
197887
228343
55320
137496
20236
76655
16119
36687
438907
695507
54424
74823
101381
207897
4404
10059

Forecast scenario 2
Baseline Counterfactual
254075
286395
229217
150001
249636
319872
175925
216733
833790
650367
42731
57065
330263
376174
328282
255027
505847
490486
146871
137513
66105
76655
39429
36690
5431452
5424026
128451
95568
577874
567162
33603
29165

Notes: The forecast period is twice the length of the sample.

35

Table 3: Decomposition of changes in effective reproduction number Rt : New York

Day
10
20
30
40
50
60

âˆ†10 log Rt
-0.547
-0.576
-0.286
-0.104
-0.098
-0.099

âˆ†10 log Î²t
-0.515
-0.461
-0.205
-0.048
-0.067
-0.084

âˆ†10 log NS(t)
(t)
-0.0316
-0.1149
-0.0813
-0.0562
-0.0316
-0.0151

Î²t (%)
94.23
80.07
71.63
45.88
67.86
84.83

S(t)
N (t)

(%)
5.77
19.93
28.37
54.12
32.14
15.17

Notes: The symbol âˆ†10 denotes a change every 10 days (i.e., in a 10-day time
interval). In the row for Day 30, for instance, the change is from Day 20 to Day 30.
with
The last two columns report the percentage contributions of log Î²t and log NS(t)
(t)
a 10-day interval. If the signs are opposite in the last two columns, the percentage
contribution can be over 100%.

Table 4: Decomposition of changes in effective reproduction number Rt : United Kingdom

Day
10
20
30
40
50
60

âˆ†10 log Rt
-1.194
-0.257
-0.340
0.028
-0.054
-0.048

âˆ†10 log Î²t
-1.188
-0.237
-0.306
0.049
-0.032
-0.029

âˆ†10 log NS(t)
(t)
-0.0060
-0.0195
-0.0331
-0.0205
-0.0223
-0.0194

Î²t (%)
99.50
92.40
90.25
172.28
58.90
59.52

S(t)
N (t)

(%)
0.50
7.60
9.75
-72.28
41.10
40.48

Notes: The symbol âˆ†10 denotes a change every 10 days (i.e., in a 10-day time
interval). In the row for Day 30, for instance, the change is from Day 20 to Day 30.
The last two columns report the percentage contributions of log Î²t and log NS(t)
with
(t)
a 10-day interval. If the signs are opposite in the last two columns, the percentage
contribution can be over 100%.

36

1200

30
Data
Estimation

Data
Estimation

25

Number per thousand

1000

800

600

400

200

20

15

10

5

0
03/20 03/27 04/03 04/10 04/17 04/24 05/01 05/08 05/15

0
03/20 03/27 04/03 04/10 04/17 04/24 05/01 05/08 05/15

Figure 1: Data and fitted paths of deaths in New York. The death pattern is fitted with one
Weibull function.

New York
1200

70

1000

60
50

800

40
600
30
400

20

200

10

0

0
0

50

100

150

0

50

100

150

Figure 2: Estimated and forecast deaths for New York. The vertical line marks the end of the
sample.

37

New York
4

3.5
3

3
2.5
2

2
1.5

1
1
0

0.5
0

50

100

150

1

0

50

100

150

0

50

100

150

0

50

100

150

6
5

0.8
4
0.6

3
2

0.4
1
0.2

0
0

50

100

150

80

100

60

50

40

0

20

-50

0

-100
0

50

100

150

Figure 3: Estimated and forecast paths for New York. The vertical line marks the end of the
sample.

38

Figure 4: Counterfactual paths for New York. The vertical line marks the end of the sample.

39

12

500
Data
Estimation

450

Data
Estimation

10
400

Number per thousand

350
300
250
200

8

6

4

150
100
2
50
0
03/25

04/01

04/08

04/15

04/22

04/29

05/06

05/13

0
03/25

05/20

04/01

04/08

04/15

04/22

04/29

05/06

05/13

05/20

Figure 5: Data and fitted paths of deaths in New Jersey. The death pattern is fitted with one
Weibull function.

New Jersey
500

35
30

400
25
300

20
15

200

10
100
5
0

0
0

50

100

150

0

50

100

150

Figure 6: Estimated and forecast deaths for New Jersey. The vertical line marks the end of the
sample.

40

New Jersey
4

4

3

3

2

2

1

1

0

0
0

50

100

150

1

0

50

100

150

0

50

100

150

0

50

100

150

5
4

0.8

3
0.6
2
0.4

1

0.2

0
0

50

100

150

80

20

60

10

40

0

20

-10

0

-20
0

50

100

150

Figure 7: Estimated and forecast paths for New Jersey. The vertical line marks the end of the
sample.

41

New Jersey (counterfactual)
4

1

3

0.8

2

0.6

1

0.4

0

0.2
0

50

100

150

2000

0

50

100

150

0

50

100

150

0

50

100

150

30
25

1500

20
1000

15
10

500

5
0

0
0

50

100

150

4

20

3

15

2

10

1

5

0

0
0

50

100

150

Figure 8: Counterfactual paths for New Jersey. The vertical line marks the end of the sample.

42

300

7
Data
Estimation

Data
Estimation

6

250

Number per thousand

5
200

150

100

4

3

2

50

1

0
03/30

04/06

04/13

04/20

04/27

05/04

05/11

0
03/30

05/18

04/06

04/13

04/20

04/27

05/04

05/11

05/18

Figure 9: Data and fitted paths of deaths in Massachusetts. The death pattern is fitted with one
Weibull function.

Massachusetts
600

25

500

20

400
15
300
10
200
5

100
0

0
0

50

100

150

0

50

100

150

Figure 10: Estimated and forecast deaths for Massachusetts. The vertical line marks the end of
the sample.

43

Massachusetts
6

6

5

5

4

4

3

3

2

2

1

1

0

0
0

50

100

150

1

8

0.8

6

0.6

4

0.4

2

0.2

0

50

100

150

0

50

100

150

0

50

100

150

0
0

50

100

150

80

30
20

60

10
40
0
20

-10

0

-20
0

50

100

150

Figure 11: Estimated and forecast paths for Massachusetts. The vertical line marks the end of
the sample.

44

Massachusetts (counterfactual)
6

1

5

0.8

4

0.6

3
0.4

2

0.2

1
0

0
0

50

100

150

3000

30

2500

25

2000

20

1500

15

1000

10

500

5

0

0

50

100

150

0

50

100

150

0

50

100

150

0
0

50

100

150

6

40

5
30
4
3

20

2
10
1
0

0
0

50

100

150

Figure 12: Counterfactual paths for Massachusetts. The vertical line marks the end of the sample.

45

250

6
Data
Estimation

Data
Estimation

5

Number per thousand

200

150

100

4

3

2

50
1

0
03/26

04/02

04/09

04/16

04/23

04/30

05/07

05/14

0
03/26

05/21

04/02

04/09

04/16

04/23

04/30

05/07

05/14

05/21

Figure 13: Data and fitted paths of deaths in Michigan. The death pattern is fitted with one
Weibull function.

Michigan
1200

40

1000
30
800
600

20

400
10
200
0

0
0

50

100

150

0

50

100

150

Figure 14: Estimated and forecast deaths for Michigan. The vertical line marks the end of the
sample.

46

Michigan
4

4

3

3

2

2

1

1

0

0
0

50

100

150

1

0

50

100

150

0

50

100

150

0

50

100

150

12
10

0.8
8
0.6

6
4

0.4
2
0.2

0
0

50

100

150

80

60
40

60
20
40

0
-20

20
-40
0

-60
0

50

100

150

Figure 15: Estimated and forecast paths for Michigan. The vertical line marks the end of the
sample.

47

Michigan (counterfactual)
4

1
0.9

3
0.8
2

0.7
0.6

1
0.5
0

0.4
0

50

100

150

1500

0

50

100

150

0

50

100

150

0

50

100

150

30
25

1000

20
15

500

10
5

0

0
0

50

100

150

4

15

3
10
2
5
1
0

0
0

50

100

150

Figure 16: Counterfactual paths for Michigan. The vertical line marks the end of the sample.

48

5

350
Data
Estimation

Data
Estimation

4.5

300
4

Number per thousand

250

200

150

3.5
3
2.5
2
1.5

100

1
50
0.5
0
03/31

04/07

04/14

04/21

04/28

05/05

05/12

0
03/31

05/19

04/07

04/14

04/21

04/28

05/05

05/12

05/19

Figure 17: Data and fitted paths of deaths in Pennsylvania. The death pattern is fitted with two
Weibull functions.

Pennsylvania
1500

50

40
1000
30

20
500
10

0

0
0

50

100

150

0

50

100

150

Figure 18: Estimated and forecast deaths for Pennsylvania. The vertical line marks the end of
the sample.

49

Pennsylvania
4

4

3

3

2

2

1

1

0

0
0

50

100

150

1

0

50

100

150

0

50

100

150

0

50

100

150

12
10

0.8
8
0.6

6
4

0.4
2
0.2

0
0

50

100

150

80

100

60

50

40

0

20

-50

0

-100
0

50

100

150

Figure 19: Estimated and forecast paths for Pennsylvania. The vertical line marks the end of the
sample.

50

Figure 20: Counterfactual paths for Pennsylvania. The vertical line marks the end of the sample.

51

5

350

300

Data
Estimation
16% percentile
84% percentile

4.5
4

250

Data
Estimation
16% percentile
84% percentile

3.5
3

200

2.5
150

2
1.5

100

1
50
0.5
0
03/31

04/07

04/14

04/21

04/28

05/05

05/12

0
03/31

05/19

04/07

04/14

04/21

04/28

05/05

05/12

05/19

Figure 21: Data and fitted paths of deaths in Pennsylvania. The death pattern is fitted with two
Weibull functions. The solid curve represents the estimated path at the posterior peak. The 68%
probability bands are represented by the dashed curve (the 16% percentile) and the dash-dotted
curve (the 84% percentile)

52

60

1600
1400

50

1200
40

1000

30

800
600

20

400
10

200
0

0
0

50

100

150

0

50

100

150

Figure 22: Death paths with uncertainty bands under the two scenarios for the normalized transmission rate during the forecast period. The vertical line marks the end of the sample. The star
or diamond curve represents the path estimated at the posterior peak. The 68% probability bands
are represented by the dashed curve (the 16% percentile) and the dash-dotted curve (the 84%
percentile)

53

8
6
4
2
0
-2
0

50

100

150

0

50

100

150

0

50

100

150

8
6
4
2
0
-2

1
0.8
0.6
0.4
0.2

Figure 23: Estimated and forecast paths with uncertainty bands under the two scenarios for the
normalized transmission rate during the forecast period. The vertical line marks the end of the
sample. The star or diamond curve represents the path estimated at the posterior peak. The 68%
probability bands are represented by the dashed curve (the 16% percentile) and the dash-dotted
curve (the 84% percentile)

54

Pennsylvania
0.09
0.1

0.08
0.07

0.08

0.06
0.06

0.05
0.04

0.04

0.03
0.02

0.02

0.01
0

0
0

0.2

0.4

0.6

0.8

1

0

0.2

0.4

0.6

0.8

Figure 24: The IS curves under the two forecast scenarios with an initial delay of 7 days.

55

1

Pennsylvania
0.06
0.1
0.05
0.08
0.04
0.06

0.03
0.02

0.04

0.01

0.02

0

0
0

0.2

0.4

0.6

0.8

1

0

0.2

0.4

0.6

0.8

1

Figure 25: The IS curves under the two forecast scenarios with an initial delay of 5 days.
Pennsylvania (counterfactual)
900

45

800

40

700

35

600

30

500

25

400

20

300

15

200

10

100

5

0

0
0

50

100

150

200

0

50

100

150

200

Figure 26: The counterfactual death paths under two forecast scenarios with an initial delay of 5
days. The vertical line marks the end of the sample.

56

Pennsylvania
0.25

0.25

0.2

0.2

0.15

0.15

0.1

0.1

0.05

0.05

0

0
0

0.2

0.4

0.6

0.8

1

0

0.2

0.4

0.6

0.8

1

Figure 27: The IS curves under the two forecast scenarios with an initial delay of 14 days.

Pennsylvania (counterfactual)
3500

60

3000

50

2500
40
2000
30
1500
20
1000
10

500
0

0
0

50

100

150

200

0

50

100

150

200

Figure 28: The counterfactual death paths under two forecast scenarios with an initial delay of
14 days. The vertical line marks the end of the sample. The red and blue curves are on top of each
other so that it is almost indistinguishable by eye.

57

200

5
Data
Estimation

180

4

140

3.5

Number per thousand

160

120
100
80

3
2.5
2

60

1.5

40

1

20

0.5

0
03/28

04/04

04/11

Data
Estimation

4.5

04/18

04/25

05/02

05/09

0
03/28

05/16

04/04

04/11

04/18

04/25

05/02

05/09

05/16

Figure 29: Data and fitted paths of deaths in Illinois. The death pattern is fitted with one Weibull
function.

Illinois
1500

50

40
1000
30

20
500
10

0

0
0

50

100

150

0

50

100

150

Figure 30: Estimated and forecast deaths for Illinois. The vertical line marks the end of the
sample.

58

Illinois
4

4

3.5
3
3
2.5

2

2
1
1.5
1

0
0

50

100

150

1

0

50

100

150

0

50

100

150

0

50

100

150

12
10

0.8
8
0.6

6
4

0.4
2
0.2

0
0

50

100

150

80

100

60

50

40

0

20

-50

0

-100
0

50

100

150

Figure 31: Estimated and forecast paths for Illinois. The vertical line marks the end of the sample.

59

Illinois (counterfactual)
4

1
0.9

3
0.8
2

0.7
0.6

1
0.5
0

0.4
0

50

100

150

0

50

100

150

0

50

100

150

0

50

100

150

40

1500

30
1000
20
500
10
0

0
0

50

100

150

4

15

3.5
3

10

2.5
2

5

1.5
1

0
0

50

100

150

Figure 32: Counterfactual paths for Illinois. The vertical line marks the end of the sample.

60

160

4
Data
Estimation

Data
Estimation

3.5

120

3

Number per thousand

140

100

80

60

2.5

2

1.5

40

1

20

0.5

0
03/24

03/31

04/07

04/14

04/21

04/28

05/05

05/12

0
03/24

05/19

03/31

04/07

04/14

04/21

04/28

05/05

05/12

05/19

Figure 33: Data and fitted paths of deaths in California. The death pattern is fitted with one
Weibull function.

California
6000

150

5000
4000

100

3000
2000

50

1000
0

0
0

50

100

150

0

50

100

150

Figure 34: Estimated and forecast deaths for California. The vertical line marks the end of the
sample.

61

California
2

2
1.8

1.5

1.6
1.4

1

1.2
1

0.5

0.8
0

50

100

150

1

0

50

100

150

0

50

100

150

0

50

100

150

15

0.8
10
0.6
5
0.4
0.2

0
0

50

100

150

80

400

60

200

40

0

20

-200

0

-400
0

50

100

150

Figure 35: Estimated and forecast paths for California. The vertical line marks the end of the
sample.

62

California (counterfactual)
2

1
0.8

1.5
0.6
1
0.4
0.5

0.2
0

50

100

150

5000

0

50

100

150

0

50

100

150

0

50

100

150

150

4000
100

3000
2000

50
1000
0

0
0

50

100

150

15

2
1.8

10

1.6
1.4

5

1.2
1

0
0

50

100

150

Figure 36: Counterfactual paths for California. The vertical line marks the end of the sample.

63

4

250
Data
Estimation

Data
Estimation

3.5
200

Number per thousand

3

150

100

2.5

2

1.5

1
50
0.5

0
03/31

04/07

04/14

04/21

04/28

05/05

05/12

0
03/31

05/19

04/07

04/14

04/21

04/28

05/05

05/12

05/19

Figure 37: Data and fitted paths of deaths in Connecticut. The death pattern is fitted with one
Weibull function.

Connecticut
250

14
12

200
10
150

8
6

100

4
50
2
0

0
0

50

100

150

0

50

100

150

Figure 38: Estimated and forecast deaths for Connecticut. The vertical line marks the end of the
sample.

64

Connecticut
3.5

3.5

3

3

2.5

2.5

2

2

1.5

1.5

1

1

0.5

0.5
0

50

100

150

1

0

50

100

150

0

50

100

150

0

50

100

150

6
5

0.8

4
0.6

3
2

0.4
1
0.2

0
0

50

100

150

80

10

60

5

40

0

20

-5

0

-10
0

50

100

150

Figure 39: Estimated and forecast paths for Connecticut. The vertical line marks the end of the
sample.

65

Connecticut (counterfactual)
1
3
0.9
2.5
0.8

2

0.7

1.5

0.6

1

0.5

0.5

0.4

0
0

50

100

150

600

12

500

10

400

8

300

6

200

4

100

2

0

0

50

100

150

0

50

100

150

0

50

100

150

0
0

50

100

150

3.5

15

3
2.5

10

2
1.5

5

1
0.5

0
0

50

100

150

Figure 40: Counterfactual paths for Connecticut. The vertical line marks the end of the sample.

66

3

140
Data
Estimation

Data
Estimation

120

2.5

Number per thousand

100

80

60

2

1.5

1

40

0.5

20

0
03/25

04/01

04/08

04/15

04/22

04/29

05/06

05/13

0
03/25

05/20

04/01

04/08

04/15

04/22

04/29

05/06

05/13

05/20

Figure 41: Data and fitted paths of deaths in Louisiana. The death pattern is fitted with one
Weibull function.

Louisiana
500

20

400

15

300
10
200
5

100

0

0
0

50

100

150

0

50

100

150

Figure 42: Estimated and forecast deaths for Louisiana. The vertical line marks the end of the
sample.

67

Louisiana
2

2

1.5

1.5

1

1

0.5

0.5
0

50

100

150

1

0

50

100

150

0

50

100

150

0

50

100

150

10
8

0.8

6
0.6
4
0.4

2

0.2

0
0

50

100

150

80

30
20

60

10
40
0
20

-10

0

-20
0

50

100

150

Figure 43: Estimated and forecast paths for Louisiana. The vertical line marks the end of the
sample.

68

Louisiana (counterfactual)
1

1.6
1.4

0.8

1.2
0.6
1
0.4

0.8
0.6

0.2
0

50

100

150

0

50

100

150

0

50

100

150

0

50

100

150

20

300
250

15
200
150

10

100
5
50
0

0
0

50

100

150

2

6
5

1.5

4
3

1

2
1

0.5

0
0

50

100

150

Figure 44: Counterfactual paths for Louisiana. The vertical line marks the end of the sample.

69

120

2.5
Data
Estimation

Data
Estimation

100

Number per thousand

2

80

60

40

1.5

1

0.5
20

0
04/04

04/11

04/18

04/25

05/02

05/09

0
04/04

05/16

04/11

04/18

04/25

05/02

05/09

05/16

Figure 45: Data and fitted paths of deaths in Maryland. The death pattern is fitted with one
Weibull function.

Maryland
800

25

20

600

15
400
10
200

5

0

0
0

50

100

0

50

100

Figure 46: Estimated and forecast deaths for Maryland. The vertical line marks the end of the
sample.

70

Maryland
2

2

1.8
1.5

1.6
1.4

1

1.2
1

0.5

0.8
0

50

100

1

0

50

100

0

50

100

0

50

100

12
10

0.8
8
0.6

6
4

0.4
2
0.2

0
0

50

100

80

60
40

60

20
40
0
20

-20

0

-40
0

50

100

Figure 47: Estimated and forecast paths for Maryland. The vertical line marks the end of the
sample.

71

Maryland (counterfactual)
2

1
0.8

1.5
0.6
1
0.4
0.5

0.2
0

50

100

500

25

400

20

300

15

200

10

100

5

0

0

50

100

0

50

100

0

50

100

0
0

50

100

8

2
1.8

6

1.6
4

1.4
1.2

2

1
0
0

50

100

Figure 48: Counterfactual paths for Maryland. The vertical line marks the end of the sample.

72

120

2.5
Data
Estimation

Data
Estimation

100

Number per thousand

2

80

60

40

1.5

1

0.5
20

0
04/04

04/11

04/18

04/25

05/02

05/09

0
04/04

05/16

04/11

04/18

04/25

05/02

05/09

05/16

Figure 49: Data and fitted paths of deaths in Maryland. The death pattern is fitted with one
Weibull function.

Maryland
800

25

20

600

15
400
10
200

5

0

0
0

50

100

0

50

100

Figure 50: Estimated and forecast deaths for Maryland. The vertical line marks the end of the
sample.

73

Maryland
2

2

1.8
1.5

1.6
1.4

1

1.2
1

0.5

0.8
0

50

100

1

0

50

100

0

50

100

0

50

100

12
10

0.8
8
0.6

6
4

0.4
2
0.2

0
0

50

100

80

60
40

60

20
40
0
20

-20

0

-40
0

50

100

Figure 51: Estimated and forecast paths for Maryland. The vertical line marks the end of the
sample.

74

Maryland (counterfactual)
2

1
0.8

1.5
0.6
1
0.4
0.5

0.2
0

50

100

500

25

400

20

300

15

200

10

100

5

0

0

50

100

0

50

100

0

50

100

0
0

50

100

8

2
1.8

6

1.6
4

1.4
1.2

2

1
0
0

50

100

Figure 52: Counterfactual paths for Maryland. The vertical line marks the end of the sample.

75

250

7
Data
Estimation

Data
Estimation

6
200

Number per thousand

5
150

100

4

3

2
50
1

0
03/23

03/30

04/06

04/13

04/20

04/27

05/04

05/11

0
03/23

05/18

03/30

04/06

04/13

04/20

04/27

05/04

05/11

05/18

Figure 53: Data and fitted paths of deaths in the South Atlantic region. The death pattern is
fitted with one Weibull function.

South Atlantic
10000

250

8000

200

6000

150

4000

100

2000

50

0

0
0

50

100

150

0

50

100

150

Figure 54: Estimated and forecast deaths for the South Atlantic region. The vertical line marks
the end of the sample.

76

South Atlantic
3.5

3
2.5

3

2

2.5

1.5

2

1

1.5

0.5

1

0

0.5
0

50

100

150

1

0

50

100

150

0

50

100

150

0

50

100

150

15

0.8
10
0.6
5
0.4
0.2

0
0

50

100

150

80

600
400

60
200
40

0
-200

20
-400
0

-600
0

50

100

150

Figure 55: Estimated and forecast paths for the South Atlantic region. The vertical line marks
the end of the sample.

77

South Atlantic (counterfactual)
3.5

1

3
0.8
2.5
0.6

2
1.5

0.4
1
0.5

0.2
0

50

100

150

3000

250

2500

200

2000

0

50

100

150

0

50

100

150

0

50

100

150

150

1500
100
1000
50

500
0

0
0

50

100

150

3.5

6

3

5

2.5

4

2

3

1.5

2

1

1

0.5

0
0

50

100

150

Figure 56: Counterfactual paths for the South Atlantic region. The vertical line marks the end
of the sample.

78

250

4.5
Data
Estimation

Data
Estimation

4

200

Number per thousand

3.5

150

100

3
2.5
2
1.5
1

50

0.5
0
03/27

04/03

04/10

04/17

04/24

05/01

05/08

0
03/27

05/15

04/03

04/10

04/17

04/24

05/01

05/08

05/15

Figure 57: Data and fitted paths of deaths in the East North Central region. The death pattern
is fitted with one Weibull function.

East North Central
100

3500
3000

80
2500
60

2000
1500

40

1000
20
500
0

0
0

50

100

150

0

50

100

150

Figure 58: Estimated and forecast deaths for the East North Central region. The vertical line
marks the end of the sample.

79

East North Central
6

6

5

5

4

4

3

3

2

2

1

1

0

0
0

50

100

150

1

0

50

100

150

0

50

100

150

0

50

100

150

15

0.8
10
0.6
5
0.4
0.2

0
0

50

100

150

80

300
200

60

100
40
0
20

-100

0

-200
0

50

100

150

Figure 59: Estimated and forecast paths for the East North Central region. The vertical line
marks the end of the sample.

80

East North Central (counterfactual)
6

1

5

0.8

4

0.6

3
0.4

2

0.2

1
0

0
0

50

100

150

8000

0

50

100

150

0

50

100

150

0

50

100

150

100
80

6000

60
4000
40
2000

20

0

0
0

50

100

150

6

30

5

25

4

20

3

15

2

10

1

5

0

0
0

50

100

150

Figure 60: Counterfactual paths for the East North Central region. The vertical line marks the
end of the sample.

81

150

3
Data
Estimation

Data
Estimation

Number per thousand

2.5

100

50

2

1.5

1

0.5

0
03/27

04/03

04/10

04/17

04/24

05/01

05/08

0
03/27

05/15

04/03

04/10

04/17

04/24

05/01

05/08

05/15

Figure 61: Data and fitted paths of deaths in the Mountain region. The death pattern is fitted
with one Weibull function.

Mountain
4000

100

80

3000

60
2000
40
1000

20

0

0
0

50

100

150

0

50

100

150

Figure 62: Estimated and forecast deaths for the Mountain region. The vertical line marks the
end of the sample.

82

Mountain
3

2.5

2.5
2

2
1.5

1.5

1
1
0.5
0

0.5
0

50

100

150

1

0

50

100

150

0

50

100

150

0

50

100

150

15

0.8
10
0.6
5
0.4
0.2

0
0

50

100

150

80

300
200

60

100
40
0
20

-100

0

-200
0

50

100

150

Figure 63: Estimated and forecast paths for the Mountain region. The vertical line marks the
end of the sample.

83

Figure 64: Counterfactual paths for the Mountain region. The vertical line marks the end of the
sample.

84

90

2.5
Data
Estimation

80

Data
Estimation

2

Number per thousand

70
60
50
40
30
20

1.5

1

0.5

10
0
03/31

04/07

04/14

04/21

04/28

05/05

05/12

0
03/31

05/19

04/07

04/14

04/21

04/28

05/05

05/12

05/19

Figure 65: Data and fitted paths of deaths in the West North Central region. The death pattern
is fitted with one Weibull function.

West North Central
100

3500
3000

80
2500
60

2000
1500

40

1000
20
500
0

0
0

50

100

150

0

50

100

150

Figure 66: Estimated and forecast deaths for the West North Central region. The vertical line
marks the end of the sample.

85

West North Central
2

2
1.8

1.5

1.6
1.4

1

1.2
1

0.5

0.8
0

50

100

150

1

0

50

100

150

0

50

100

150

0

50

100

150

15

0.8
10
0.6
5
0.4
0.2

0
0

50

100

150

80

200

60

100

40

0

20

-100

0

-200
0

50

100

150

Figure 67: Estimated and forecast paths for the West North Central region. The vertical line
marks the end of the sample.

86

West North Central (counterfactual)
2

1
0.8

1.5
0.6
1
0.4
0.5

0.2
0

50

100

150

3000

100

2500

80

2000

0

50

100

150

0

50

100

150

0

50

100

150

60

1500
40

1000

20

500
0

0
0

50

100

150

2

15

1.8
10

1.6
1.4

5

1.2
1

0
0

50

100

150

Figure 68: Counterfactual paths for the West North Central region. The vertical line marks the
end of the sample.

87

2

70
Data
Estimation

Data
Estimation

1.8

60
1.6

Number per thousand

50

40

30

1.4
1.2
1
0.8
0.6

20

0.4
10
0.2
0
03/29

04/05

04/12

04/19

04/26

05/03

05/10

0
03/29

05/17

04/05

04/12

04/19

04/26

05/03

05/10

05/17

Figure 69: Data and fitted paths of deaths in the West South Central region. The death pattern
is fitted with one Weibull function.

West South Central
5000

140
120

4000
100
3000

80
60

2000

40
1000
20
0

0
0

50

100

150

0

50

100

150

Figure 70: Estimated and forecast deaths for the West South Central region. The vertical line
marks the end of the sample.

88

West South Central
2

2

1.8
1.5

1.6
1.4

1

1.2
1

0.5

0.8
0

50

100

150

1

0

50

100

150

0

50

100

150

0

50

100

150

15

0.8
10
0.6
5
0.4

0.2

0
0

50

100

150

80

300
200

60
100
40

0
-100

20
-200
0

-300
0

50

100

150

Figure 71: Estimated and forecast paths for the West South Central region. The vertical line
marks the end of the sample.

89

West South Central (counterfactual)
2

1

0.8
1.5
0.6
1
0.4
0.5

0.2
0

50

100

150

0

50

100

150

0

50

100

150

0

50

100

150

150

5000
4000

100
3000
2000
50
1000
0

0
0

50

100

150

2

12

1.8

10

1.6

8

1.4

6

1.2

4

1

2

0.8

0
0

50

100

150

Figure 72: Counterfactual paths for the West South Central region. The vertical line marks the
end of the sample.

90

80

2
Data
Estimation

Data
Estimation

1.8

70

1.6

Number per thousand

60

50

40

30

1.4
1.2
1
0.8
0.6

20
0.4
10

0.2

0
03/30

04/06

04/13

04/20

04/27

05/04

05/11

0
03/30

05/18

04/06

04/13

04/20

04/27

05/04

05/11

05/18

Figure 73: Data and fitted paths of deaths in the East South Central region. The death pattern
is fitted with one Weibull function.

East South Central
3000

80

2500
60
2000
1500

40

1000
20
500
0

0
0

50

100

150

0

50

100

150

Figure 74: Estimated and forecast deaths for the East South Central region. The vertical line
marks the end of the sample.

91

East South Central
2

2

1.8
1.5

1.6
1.4

1

1.2
1

0.5

0.8
0

50

100

150

1

0

50

100

150

0

50

100

150

0

50

100

150

15

0.8
10
0.6
5
0.4
0.2

0
0

50

100

150

80

200

60

100

40

0

20

-100

0

-200
0

50

100

150

Figure 75: Estimated and forecast paths for the East South Central region. The vertical line
marks the end of the sample.

92

East South Central (counterfactual)
1

2

0.8
1.5
0.6
1
0.4
0.5

0.2
0

50

100

150

0

50

100

150

0

50

100

150

0

50

100

150

80

3000
2500

60
2000
1500

40

1000
20
500
0

0
0

50

100

150

15

2
1.8

10

1.6
1.4

5

1.2
1

0
0

50

100

150

Figure 76: Counterfactual paths for the East South Central region. The vertical line marks the
end of the sample.

93

45

1.4
Data
Estimation

40

Data
Estimation

1.2
35

Number per thousand

1
30
25
20
15

0.8

0.6

0.4
10
0.2
5
0
03/17 03/24 03/31 04/07 04/14 04/21 04/28 05/05 05/12 05/19

0
03/17 03/24 03/31 04/07 04/14 04/21 04/28 05/05 05/12 05/19

Figure 77: Data and fitted paths of deaths in the Pacific region. The death pattern is fitted with
one Weibull function.

Pacific
2500

60
50

2000

40
1500
30
1000
20
500

10

0

0
0

50

100

150

0

50

100

150

Figure 78: Estimated and forecast deaths for the Pacific region. The vertical line marks the end
of the sample.

94

Pacific
2.5
2
2
1.5

1.5
1

1
0.5
0

0.5
0

50

100

150

1

0

50

100

150

0

50

100

150

0

50

100

150

15

0.8
10
0.6
5
0.4
0.2

0
0

50

100

150

80

150
100

60
50
40

0
-50

20
-100
0

-150
0

50

100

150

Figure 79: Estimated and forecast paths for the Pacific region. The vertical line marks the end
of the sample.

95

Pacific (counterfactual)
2.5

1

2

0.8

1.5

0.6

1

0.4

0.5

0.2
0

50

100

150

2000

0

50

100

150

0

50

100

150

0

50

100

150

60
50

1500
40
1000

30
20

500
10
0

0
0

50

100

150

12
2
10
8

1.5

6
4

1

2
0.5

0
0

50

100

150

Figure 80: Counterfactual paths for the Pacific region. The vertical line marks the end of the
sample.

96

40

0.9
Data
Estimation

Data
Estimation

0.8

35

0.7

Number per thousand

30

25

20

15

10

0.6
0.5
0.4
0.3
0.2

5

0.1

0
04/04

04/11

04/18

04/25

05/02

05/09

0
04/04

05/16

04/11

04/18

04/25

05/02

05/09

05/16

Figure 81: Data and fitted paths of deaths in the New England region. The death pattern is
fitted with one Weibull function.

New England
600

20

500
15
400
300

10

200
5
100
0

0
0

50

100

0

50

100

Figure 82: Estimated and forecast deaths for the New England region. The vertical line marks
the end of the sample.

97

New England
2.5

2.5

2

2

1.5
1.5
1
1

0.5
0

0.5
0

50

100

1

0

50

100

0

50

100

0

50

100

15

0.8
10
0.6
5
0.4
0.2

0
0

50

100

80

40

60

20

40

0

20

-20

0

-40
0

50

100

Figure 83: Estimated and forecast paths for the New England region. The vertical line marks the
end of the sample.

98

New England (counterfactual)
2.5

1

2

0.8

1.5

0.6

1

0.4

0.5

0.2
0

50

100

400

0

50

100

0

50

100

0

50

100

15

300
10
200
5

100
0

0
0

50

100

2.5

10
8

2

6
1.5
4
1

2

0.5

0
0

50

100

Figure 84: Counterfactual paths for the New England region. The vertical line marks the end of
the sample.

99

A

Empirical results for other countries

For all the countries reported below, Î³ = 0.2 except for France and Mexico where Î³
is set to 0.5 to keep Î²t positive during the sample period.

100

40

1200
Data
Estimation

Data
Estimation

35
1000

Number per thousand

30
800

600

400

25

20

15

10
200
5

0
03/16 03/23 03/30 04/06 04/13 04/20 04/27 05/04 05/11 05/18

0
03/16 03/23 03/30 04/06 04/13 04/20 04/27 05/04 05/11 05/18

Figure A.1: Data and fitted paths of deaths in United Kingdom. The death pattern is fitted with
a mixture of two Weibull functions.

UK
7000

300

6000

250

5000

200

4000
150
3000
100

2000

50

1000
0

0
0

50

100

150

0

50

100

150

Figure A.2: Estimated and forecast deaths for United Kingdom. The vertical line marks the end
of the sample.

101

UK
6

6

5

5

4

4

3

3

2

2

1

1

0

0
0

50

100

150

1

0

50

100

150

0

50

100

150

0

50

100

150

10
8

0.8

6
0.6
4
0.4

2

0.2

0
0

50

100

150

80

400

60

200

40

0

20

-200

0

-400
0

50

100

150

Figure A.3: Estimated and forecast paths for United Kingdom. The vertical line marks the end
of the sample.

102

Figure A.4: Counterfactual paths for United Kingdom. The vertical line marks the end of the
sample.

103

1000

35
Data
Estimation

900

Data
Estimation

30
800
25

Number per thousand

700
600
500
400
300

20

15

10

200
5
100
0
03/02 03/09 03/16 03/23 03/30 04/06 04/13 04/20 04/27 05/04 05/11 05/18

0
03/02 03/09 03/16 03/23 03/30 04/06 04/13 04/20 04/27 05/04 05/11 05/18

Figure A.5: Data and fitted paths of deaths in Italy. The death pattern is fitted with a mixture
of two Weibull functions.

Italy
250

7000
6000

200
5000
150

4000
3000

100

2000
50
1000
0

0
0

50

100

150

200

0

50

100

150

200

Figure A.6: Estimated and forecast deaths for Italy. The vertical line marks the end of the
sample.

104

Italy
3.5

3

3

2.5

2.5

2
1.5

2

1

1.5

0.5

1

0

0.5
0

50

100

150

200

1

0

50

100

150

200

0

50

100

150

200

0

50

100

150

200

12
10

0.8
8
0.6

6
4

0.4
2
0.2

0
0

50

100

150

200

80

400

60

200

40

0

20

-200

0

-400
0

50

100

150

200

Figure A.7: Estimated and forecast paths for Italy. The vertical line marks the end of the sample.

105

Figure A.8: Counterfactual paths for Italy. The vertical line marks the end of the sample.

106

30

1600
Data
Estimation

1400

Data
Estimation

25
1200

Number per thousand

1000
800
600
400

20

15

10

200
0
5
-200
-400
03/13 03/20 03/27 04/03 04/10 04/17 04/24 05/01 05/08 05/15

0
03/13 03/20 03/27 04/03 04/10 04/17 04/24 05/01 05/08 05/15

Figure A.9: Data and fitted paths of deaths in France. The death pattern is fitted with a mixture
of two Weibull functions.

France

10 5

3

3000

2.5

2500

2

2000

1.5

1500

1

1000

0.5

500

0

0
0

50

100

150

200

0

50

100

150

200

Figure A.10: Estimated and forecast deaths for France. The vertical line marks the end of the
sample.

107

France
5

5

4

4

3

3

2

2

1

1

0

0
0

50

100

150

200

1

0

50

100

150

200

0

50

100

150

200

50

100

150

200

15

0.8
10
0.6
5
0.4

0.2

0
0

50

100

150

200

80

10 4

6
4

60

2
40
0
20

-2

0

-4
0

50

100

150

200

0

Figure A.11: Estimated and forecast paths for France. The vertical line marks the end of the
sample.

108

Figure A.12: Counterfactual paths for France. The vertical line marks the end of the sample.

109

30

1000
Data
Estimation

900

Data
Estimation

25
800

Number per thousand

700
600
500
400

20

15

10

300
200
5
100
0
03/11 03/18 03/25 04/01 04/08 04/15 04/22 04/29 05/06 05/13 05/20

0
03/11 03/18 03/25 04/01 04/08 04/15 04/22 04/29 05/06 05/13 05/20

Figure A.13: Data and fitted paths of deaths in Spain. The death pattern is fitted with a mixture
of two Weibull functions.

Spain
5000

200

4000

150

3000
100
2000
50

1000

0

0
0

50

100

150

200

0

50

100

150

200

Figure A.14: Estimated and forecast deaths for Spain. The vertical line marks the end of the
sample.

110

Spain
6

6

5

5

4

4

3

3

2

2

1

1

0

0
0

50

100

150

200

1

0

50

100

150

200

0

50

100

150

200

0

50

100

150

200

10
8

0.8

6
0.6
4
0.4

2

0.2

0
0

50

100

150

200

80

300
200

60

100
40
0
20

-100

0

-200
0

50

100

150

200

Figure A.15: Estimated and forecast paths for Spain. The vertical line marks the end of the
sample.

111

Figure A.16: Counterfactual paths for Spain. The vertical line marks the end of the sample.

112

1200

25
Data
Estimation

Data
Estimation

1000

Number per thousand

20

800

600

400

15

10

5
200

0
03/25

04/01

04/08

04/15

04/22

04/29

05/06

05/13

0
03/25

05/20

04/01

04/08

04/15

04/22

04/29

05/06

05/13

05/20

Figure A.17: Data and fitted paths of deaths in Brazil. The death pattern is fitted with a mixture
of two Weibull functions.

Brazil
10

3.5

4

1000

3
800
2.5
600

2
1.5

400

1
200
0.5
0

0
0

50

100

150

0

50

100

150

Figure A.18: Estimated and forecast deaths for Brazil. The vertical line marks the end of the
sample.

113

Brazil
5

4

4

3.5
3

3

2.5
2
2
1

1.5

0

1
0

50

100

150

1

0

50

100

150

0

50

100

150

0

50

100

150

15

0.8
10
0.6
5
0.4
0.2

0
0

50

100

150

80

2000

60

1000

40

0

20

-1000

0

-2000
0

50

100

150

Figure A.19: Estimated and forecast paths for Brazil. The vertical line marks the end of the
sample.

114

Figure A.20: Counterfactual paths for Brazil. The vertical line marks the end of the sample.

115

4

200
Data
Estimation

180

Data
Estimation

3.5

160
3

Number per thousand

140
120
100
80

2.5

2

1.5

60
1
40
0.5

20
0
03/25

04/01

04/08

04/15

04/22

04/29

05/06

05/13

0
03/25

05/20

04/01

04/08

04/15

04/22

04/29

05/06

05/13

05/20

Figure A.21: Data and fitted paths of deaths in Sweden. The death pattern is fitted with a
mixture of two Weibull functions.

Sweden
40

1400
1200

30

1000
800

20
600
400

10

200
0

0
0

50

100

150

0

50

100

150

Figure A.22: Estimated and forecast deaths for Sweden. The vertical line marks the end of the
sample.

116

Sweden
5

5

4

4

3

3

2

2

1

1

0

0
0

50

100

150

1

0

50

100

150

0

50

100

150

0

50

100

150

12
10

0.8
8
0.6

6
4

0.4
2
0.2

0
0

50

100

150

80

100

60
50
40
0
20
-50

0
0

50

100

150

Figure A.23: Estimated and forecast paths for Sweden. The vertical line marks the end of the
sample.

117

Sweden (counterfactual)
5

1

4

0.8

3
0.6
2
0.4

1
0

0.2
0

50

100

150

2500

0

50

100

150

0

50

100

150

0

50

100

150

40

2000

30

1500
20
1000
10

500
0

0
0

50

100

150

5

25

4

20

3

15

2

10

1

5

0

0
0

50

100

150

Figure A.24: Counterfactual paths for Sweden. The vertical line marks the end of the sample.

118

500

10
Data
Estimation

450

8

350

7

Number per thousand

400

300
250
200

6
5
4

150

3

100

2

50

1

0
03/21

03/28

04/04

04/11

04/18

04/25

05/02

05/09

Data
Estimation

9

0
03/21

05/16

03/28

04/04

04/11

04/18

04/25

05/02

05/09

05/16

Figure A.25: Data and fitted paths of deaths in Belgium. The death pattern is fitted with a
mixture of two Weibull functions.

Belgium
1200

50

1000

40

800
30
600
20
400
10

200
0

0
0

50

100

150

0

50

100

150

Figure A.26: Estimated and forecast deaths for Belgium. The vertical line marks the end of the
sample.

119

Belgium
10

10

8

8

6

6

4

4

2

2

0

0
0

50

100

150

1

0

50

100

150

0

50

100

150

0

50

100

150

10
8

0.8

6
0.6
4
0.4

2

0.2

0
0

50

100

150

80

60
40

60
20
40

0
-20

20
-40
0

-60
0

50

100

150

Figure A.27: Estimated and forecast paths for Belgium. The vertical line marks the end of the
sample.

120

Belgium (counterfactual)
10

1

8

0.8

6

0.6

4

0.4

2

0.2

0

0
0

50

100

150

8000

0

50

100

150

0

50

100

150

0

50

100

150

60
50

6000
40
4000

30
20

2000
10
0

0
0

50

100

150

10

60

8

50

6

40
30

4
20
2

10

0

0
0

50

100

150

Figure A.28: Counterfactual paths for Belgium. The vertical line marks the end of the sample.

121

9

600
Data
Estimation

Data
Estimation

8

500
7

Number per thousand

400

300

200

6
5
4
3

100
2
0
1
-100
03/20 03/27 04/03 04/10 04/17 04/24 05/01 05/08 05/15

0
03/20 03/27 04/03 04/10 04/17 04/24 05/01 05/08 05/15

Figure A.29: Data and fitted paths of deaths in Germany. The death pattern is fitted with a
mixture of two Weibull functions.

Germany
14000

350

12000

300

10000

250

8000

200

6000

150

4000

100

2000

50

0

0
0

50

100

150

0

50

100

150

Figure A.30: Estimated and forecast deaths for Germany. The vertical line marks the end of the
sample.

122

Germany
8

8

6

6

4

4

2

2
0

0
0

50

100

150

1

0

50

100

150

0

50

100

150

0

50

100

150

15

0.8
10
0.6
5
0.4
0.2

0
0

50

100

150

80

1000

60

500

40
0
20
-500
0
0

50

100

150

Figure A.31: Estimated and forecast paths for Germany. The vertical line marks the end of the
sample.

123

Germany (counterfactual)
8

1
0.8

6

0.6
4
0.4
2

0.2

0

0
0

50

100

150

104

4

0

50

100

150

0

50

100

150

0

50

100

150

400

3

300

2

200

1

100

0

0
0

50

100

150

50

8

40

6

30
4
20
2

10

0

0
0

50

100

150

Figure A.32: Counterfactual paths for Germany. The vertical line marks the end of the sample.

124

160

8
Data
Estimation

Data
Estimation

7

120

6

Number per thousand

140

100

80

60

5

4

3

40

2

20

1

0
03/01 03/08 03/15 03/22 03/29 04/05 04/12 04/19 04/26 05/03 05/10 05/17

0
03/01 03/08 03/15 03/22 03/29 04/05 04/12 04/19 04/26 05/03 05/10 05/17

Figure A.33: Data and fitted paths of deaths in Iran. The death pattern is fitted with a mixture
of two Weibull functions.

Iran
14000

350

12000

300

10000

250

8000

200

6000

150

4000

100

2000

50

0

0
0

50

100

150

200

0

50

100

150

200

Figure A.34: Estimated and forecast deaths for Iran. The vertical line marks the end of the
sample.

125

Iran
6

6

5

5

4

4

3

3

2

2

1

1

0

0
0

50

100

150

200

1

0

50

100

150

200

0

50

100

150

200

0

50

100

150

200

15

0.8
10
0.6
5
0.4
0.2

0
0

50

100

150

200

80

1000

60

500

40
0
20
-500

0
0

50

100

150

200

Figure A.35: Estimated and forecast paths for Iran. The vertical line marks the end of the
sample.

126

Figure A.36: Counterfactual paths for Iran. The vertical line marks the end of the sample.

127

450

7
Data
Estimation

400

Data
Estimation

6
350

Number per thousand

5
300
250
200
150

4

3

2
100
1
50
0
04/02

04/09

04/16

04/23

04/30

05/07

05/14

0
04/02

05/21

04/09

04/16

04/23

04/30

05/07

05/14

05/21

Figure A.37: Data and fitted paths of deaths in Mexico. The death pattern is fitted with a
mixture of two Weibull functions.
Mexico

10 5

5

6000
5000

4

4000
3
3000
2
2000
1

1000

0

0
0

50

100

0

50

100

Figure A.38: Estimated and forecast deaths for Mexico. The vertical line marks the end of the
sample.

128

Mexico
2

2

1.5

1.5

1

1

0.5

0.5
0

50

100

1

0

50

100

0

50

100

50

100

15

0.8
10
0.6
5

0.4

0.2

0
0

50

100

80

1

60

0.5

40

0

20

-0.5

0

10 5

-1
0

50

100

0

Figure A.39: Estimated and forecast paths for Mexico. The vertical line marks the end of the
sample.

129

Figure A.40: Counterfactual paths for Mexico. The vertical line marks the end of the sample.

130

300

7
Data
Estimation

Data
Estimation

6

250

Number per thousand

5
200

150

100

4

3

2

50

1

0
03/27

04/03

04/10

04/17

04/24

05/01

05/08

0
03/27

05/15

04/03

04/10

04/17

04/24

05/01

05/08

05/15

Figure A.41: Data and fitted paths of deaths in Canada. The death pattern is fitted with a
mixture of two Weibull functions.

Canada
6000

150

5000
4000

100

3000
2000

50

1000
0

0
0

50

100

150

0

50

100

150

Figure A.42: Estimated and forecast deaths for Canada. The vertical line marks the end of the
sample.

131

Canada
6

6

5

5

4

4

3

3

2

2

1

1

0

0
0

50

100

150

1

0

50

100

150

0

50

100

150

0

50

100

150

15

0.8
10
0.6
5
0.4
0.2

0
0

50

100

150

80

400
300

60

200
100

40

0
20

-100
-200

0
0

50

100

150

Figure A.43: Estimated and forecast paths for Canada. The vertical line marks the end of the
sample.

132

Canada (counterfactual)
6

1

5
0.8
4
0.6

3
2

0.4
1
0

0.2
0

50

100

150

10000

0

50

100

150

0

50

100

150

0

50

100

150

150

8000
100

6000
4000

50

2000
0

0
0

50

100

150

6

25

5

20

4

15

3
10

2

5

1
0

0
0

50

100

150

Figure A.44: Counterfactual paths for Canada. The vertical line marks the end of the sample.

133

250

6
Data
Estimation

Data
Estimation

5

Number per thousand

200

150

100

4

3

2

50
1

0
03/18 03/25 04/01 04/08 04/15 04/22 04/29 05/06 05/13 05/20

0
03/18 03/25 04/01 04/08 04/15 04/22 04/29 05/06 05/13 05/20

Figure A.45: Data and fitted paths of deaths in Netherlands. The death pattern is fitted with a
mixture of two Weibull functions.

Netherlands
2500

70
60

2000
50
1500

40
30

1000

20
500
10
0

0
0

50

100

150

0

50

100

150

Figure A.46: Estimated and forecast deaths for Netherlands. The vertical line marks the end of
the sample.

134

Netherlands
6

6

5

5

4

4

3

3

2

2

1

1

0

0
0

50

100

150

1

0

50

100

150

0

50

100

150

0

50

100

150

15

0.8
10
0.6
5
0.4
0.2

0
0

50

100

150

80

150
100

60

50
40
0
20

-50

0

-100
0

50

100

150

Figure A.47: Estimated and forecast paths for Netherlands. The vertical line marks the end of
the sample.

135

Netherlands (counterfactual)
6

1

5

0.8

4

0.6

3
0.4
2
0.2

1
0

0
0

50

100

150

8000

80

6000

60

4000

40

2000

20

0

0

50

100

150

0

50

100

150

0

50

100

150

0
0

50

100

150

6

50

5

40

4

30

3
20
2
10

1
0

0
0

50

100

150

Figure A.48: Counterfactual paths for Netherlands. The vertical line marks the end of the sample.

136

4

180
Data
Estimation

160

Data
Estimation

3.5

140

Number per thousand

3

120
100
80
60

2.5

2

1.5

1

40

0.5

20
0
04/01

04/08

04/15

04/22

04/29

05/06

05/13

0
04/01

05/20

04/08

04/15

04/22

04/29

05/06

05/13

05/20

Figure A.49: Data and fitted paths of deaths in India. The death pattern is fitted with a mixture
of two Weibull functions.

India
10

2.5

5

6000
5000

2

4000
1.5
3000
1
2000
0.5

1000

0

0
0

50

100

150

0

50

100

150

Figure A.50: Estimated and forecast deaths for India. The vertical line marks the end of the
sample.

137

India
2

2
1.8

1.5

1.6
1.4

1

1.2
1

0.5

0.8
0

50

100

150

1

0

50

100

150

0

50

100

150

50

100

150

15

0.8
10
0.6
5
0.4
0.2

0
0

50

100

150

80

104

1.5
1

60
0.5
40

0
-0.5

20
-1
0

-1.5
0

50

100

150

0

Figure A.51: Estimated and forecast paths for India. The vertical line marks the end of the
sample.

138

India (counterfactual)
1

2

0.8

1.5

0.6
1
0.4
0.5

0.2
0

50

100

150

105

2.5

0

50

100

150

0

50

100

150

0

50

100

150

6000
5000

2

4000

1.5

3000
1

2000

0.5

1000

0

0
0

50

100

150

2

15

1.8
10

1.6
1.4

5
1.2
1

0
0

50

100

150

Figure A.52: Counterfactual paths for India. The vertical line marks the end of the sample.

139

150

3.5
Data
Estimation

Data
Estimation

3

Number per thousand

2.5
100

50

2

1.5

1

0.5

0
04/02

04/09

04/16

04/23

04/30

05/07

05/14

0
04/02

05/21

04/09

04/16

04/23

04/30

05/07

05/14

05/21

Figure A.53: Data and fitted paths of deaths in Peru. The death pattern is fitted with a mixture
of two Weibull functions.

Peru
5000

140
120

4000
100
3000

80
60

2000

40
1000
20
0

0
0

50

100

0

50

100

Figure A.54: Estimated and forecast deaths for Peru. The vertical line marks the end of the
sample.

140

Peru
5

4
3.5

4

3

3

2.5
2
2
1

1.5
1

0
0

50

100

1

0

50

100

0

50

100

0

50

100

15

0.8
10
0.6
5
0.4
0.2

0
0

50

100

80

400
300

60

200
100

40

0
20

-100
-200

0
0

50

100

Figure A.55: Estimated and forecast paths for Peru. The vertical line marks the end of the
sample.

141

Peru (counterfactual)
5

1

4

0.9
0.8

3

0.7
2

0.6

1

0.5

0

0.4
0

50

100

2500

100

2000

80

1500

60

1000

40

500

20

0

0

50

100

0

50

100

0

50

100

0
0

50

100

8

4
3.5

6

3
4

2.5
2

2
1.5
1

0
0

50

100

Figure A.56: Counterfactual paths for Peru. The vertical line marks the end of the sample.

142

140

3.5
Data
Estimation

Data
Estimation

3

100

2.5

Number per thousand

120

80

60

2

1.5

40

1

20

0.5

0
04/07

04/14

04/21

04/28

05/05

05/12

0
04/07

05/19

04/14

04/21

04/28

05/05

05/12

05/19

Figure A.57: Data and fitted paths of deaths in Russia. The death pattern is fitted with a mixture
of two Weibull functions.

Russia
10

2.5

4

600
500

2

400
1.5
300
1
200
0.5

100

0

0
0

50

100

0

50

100

Figure A.58: Estimated and forecast deaths for Russia. The vertical line marks the end of the
sample.

143

Russia
3

3

2.5

2.5

2

2

1.5
1.5

1

1

0.5
0

0.5
0

50

100

1

0

50

100

0

50

100

0

50

100

15

0.8
10
0.6
5
0.4
0.2

0
0

50

100

2000

80

1500
60
1000
500

40

0
20

-500
-1000

0
0

50

100

Figure A.59: Estimated and forecast paths for Russia. The vertical line marks the end of the
sample.

144

Russia (counterfactual)
3

1

2.5
0.8
2
0.6

1.5
1

0.4
0.5
0

0.2
0

50

100

104

2

0

50

100

0

50

100

0

50

100

600
500

1.5
400
1

300
200

0.5
100
0

0
0

50

100

3

15

2.5
10

2
1.5

5

1
0.5

0
0

50

100

Figure A.60: Counterfactual paths for Russia. The vertical line marks the end of the sample.

145

80

2
Data
Estimation

Data
Estimation

1.8

70

1.6

Number per thousand

60

50

40

30

1.4
1.2
1
0.8
0.6

20
0.4
10

0.2

0
03/20 03/27 04/03 04/10 04/17 04/24 05/01 05/08 05/15

0
03/20 03/27 04/03 04/10 04/17 04/24 05/01 05/08 05/15

Figure A.61: Data and fitted paths of deaths in Switzerland. The death pattern is fitted with a
mixture of two Weibull functions.

Switzerland
1200

35

1000

30
25

800

20
600
15
400

10

200

5

0

0
0

50

100

150

0

50

100

150

Figure A.62: Estimated and forecast deaths for Switzerland. The vertical line marks the end of
the sample.

146

Switzerland
3

3

2.5

2.5

2

2

1.5

1.5

1

1

0.5

0.5

0

0
0

50

100

150

1

0

50

100

150

0

50

100

150

0

50

100

150

15

0.8
10
0.6
5
0.4
0.2

0
0

50

100

150

80

100

60
50
40
0
20
-50

0
0

50

100

150

Figure A.63: Estimated and forecast paths for Switzerland. The vertical line marks the end of
the sample.

147

Switzerland (counterfactual)
3

1

2.5
0.8
2
0.6

1.5
1

0.4
0.5
0

0.2
0

50

100

150

500

30

400

25

0

50

100

150

0

50

100

150

0

50

100

150

20

300

15
200

10

100

5

0

0
0

50

100

150

3

6

2.5

5

2

4

1.5

3

1

2

0.5

1

0

0
0

50

100

150

Figure A.64: Counterfactual paths for Switzerland. The vertical line marks the end of the sample.

148

